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ABSTRACT
A 29 5 kDa cysteine proteinase was purified from medium m which mature 
Fasciola hepatica  parasites were maintained The N-terminal sequence (14 
amino acid residues) of the purified protein is homologous to known 
cathepsin L proteinases, including a 27 kDa cathepsin L proteinase, also 
secreted by this parasite, which had been isolated previously in our 
laboratory (Smith e t a l  , Mol Biochem Parasitol.,62,1-8,1993) The N- 
terminal sequences of the 29 5 and 27 kDa cathepsin L proteinases differ 
only in residue seven ( arginine and proline, respectively) Immunoblot 
studies, using antiserum that reacts with both cathepsin Ls, rule out the 
possibility of both enzymes ansing from a higher molecular sized parent 
molecule The reaction kinetics of the two F hepatica  cathepsin Ls on a 
variety of peptide substrates revealed that the two enzymes differ in their 
substrate specificity Five peptide substrates that are cleaved with high 
affinity by the 29 5 kDa cathepsin L isolated m this study are not cleaved by 
the previously purified 27 kDa cathepsin L The protein modifying reagent, 
tetramtromethane, affected the 29 5 kDa cathepsin L proteinase only, 
causing inactivation of the enzyme and changing its migration in 
polyacrylamide gels Our studies suggest that the two F  hepatica  cysteine 
proteinases represent two distinct subclasses within the cathepsin L class 
The 29 5 kDa cathepsin L can cleave fibnnogen and produce a fibrin clot in  
vitro This is the first demonstration of a cysteine proteinase with the ability to 
clot fibnnogen The mechanism of clot formation of the cathepsin L was 
compared to bovine thrombin SDS-PAGE analysis of clots showed 
differences in enzyme activities between the two proteinases Cathepsin L 
was also not inhibited by the thrombin specific inhibitor hirudin Studies 
using peptides which prevent fibnn polymerisation showed that the fibrin clot 
formed by cathepsin L polymerises in a different manner to the clot formed 
by thrombin Clotting time assays in the presence of anti-polymerisation 
peptides and SDS-PAGE analysis of these clots showed that the cathepsin L 
fibrinogen cleavage site was located to the C-terminal of the thrombin 
cleavage site Therefore F  hepatica  cathepsin L forms a fibrin clot by a 
novel mechanism and may represent a means whereby F. hepatica  may 
prevent excessive blood loss while migrating through host tissue
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CHAPTER 1 
INTRODUCTION
4
1.1 PROTEINASES
Proteolytic cleavage of peptide bonds is one of the most important 
enzymatic modifications of proteins Investigations of kinetics, substrate 
specificity, inhibition, amino acid composition and X-ray structural data have 
led to the identification of the components of their active sites, and from these 
studies the mechanism of action of the best characterised proteinases were 
deduced As a result it became evident that proteinases can be classified 
into families, members of each family having similar structures and 
mechanisms of action Four mechanistic classes are recognised by the 
International Union of Biochemistry, and within these classes, six families of 
proteinases are recognised to date These classes are as follows serine 
proteinases I and II, cysteine proteinases, aspartic proteinases, and the 
metalloproteinases I and II (Neurath, 1989)
1.1.1 SERINE PROTEINASES
The serine proteinases include two distinct families the mammalian 
serine proteinases (e g chymotrypsin (EC 3 4 21 1), trypsin (EC 3 4 21 4) 
and elastase (EC 3 4 21 11)) and the bacterial serine proteinases (e g 
subtilisin (EC 3 4 21 14)) Serine proteinases contain an essential serine 
residue at the catalytic site The hydroxyl group of this serine attacks the 
carbonyl group of a peptide bond to form a tetrahedral intermediate pnor to 
hydrolysis (Figure 1 1) This intermediate is stabilised by hydrogen bonding 
of the oxygen anion Déacylation of the intermediate is catalysed by the 
addition of a proton from the imidazole group of a histidine These amino 
acids are essential for hydrolysis
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Figure 1.1
Schematic representation of the steps involved m catalysis by the senne 
peptidase type of enzyme.
The reaction proceeds through formation of a tetrahedral intermediate 
followed by loss of the right-hand half of the substrate to give an acyl enzyme 
intermediate. Breakdown of that intermediate occurrs by enzyme-catalysed 
attack of water to generate the product acid (Taken from Dunn, 1989).
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1.1.2 ASPARTIC PROTEINASES
The major intracellular mammalian aspartic proteinases are cathepsm 
D and rennin The precise mechanism of action of aspartic proteinases is 
not clear, but may be a simple acid-base type of mechanism at acidic pH 
involving the carboxyl side chains of the two essential aspartic acid residues 
(Figure 1 2) A potent inhibitor of aspartic proteinases is pepstatin, which is 
a hexapeptide that in the transition state resembles normal substrates
1.1.3 METALLOPROTEINASES
This class of enzymes includes the matrix metalloproteinases that are 
inhibited by a protein called TIMP ( tissue inhibitor of metalloproteinases) 
and plasma membrane-bound metalloproteinases such as endopeptidase 
24 11 (enkephalinase) and meprin, for which no natural proteinase inhibitors 
are known Metalloproteinases coordinate a zinc ion with the aid of glutamic 
acid and histidine residues It has been proposed that the zinc ion acts as an 
electrophile to enhance the reactivity of the carbonyl group of the amino acid 
whose peptide bond is to be hydrolysed to facilitate nucleophilic attack by a 
water molecule (Figure 1 3)
1.1.4 CYSTEINE PROTEINASES
The major mammalian cysteine proteinases are the cytoplasmic 
calpains and the lysosomal cysteine proteinases, e g cathepsins B,H and L 
(c f part 1 2) The calpains are calcium dependent proteinases that consist
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of two subunits of 80 kDa and 30 kDa One portion of the larger subunit 
carries a sequence that shows a small degree of identity with papain, but the 
degree of identity is insufficient to show whether or not they are evolutionally 
related All cysteine proteinases have a catalytic triad consisting of essential 
cysteine, histidine and asparagine residues The mechanism of action is 
similar to that of serine proteinases except that the sulphomum ion of the 
cysteine provides the nucleophilic attack on the carbonyl group of the 
peptide bond (Figure 1 4) Both calpain and the lysosomal cysteine 
proteinases are inhibited by the class-specific inhibitor E-64, and the more 
general inhibitor, leupeptm
1.2 MAMMALIAN CATHEPSINS
The mammalian cathepsins are lysosomal proteinases and are 
present in all cell types with the exception of enucleated red blood cells 
These enzymes are cysteine proteinases with two exceptions, cathepsins D 
and E which belong to the aspartic class The mammalian cathepsins are 
mainly involved in protein turnover in tissues and may be the most active 
proteinases in the body, even more active than the digestive pancreatic 
serine proteinases (Bond and Butler, 1987) Of the lysosomal enzymes, the 
aspartic proteinase, cathepsin D, seems to have rather a restricted activity on 
proteins, whereas the cysteine proteinases have broad activity (Bond and 
Butler, 1987)
The amino acid sequences of some of the cysteinyl cathepsins have 
been elucidated and it is now known that these enzymes have evolved from 
the same ancestor as the plant cysteine proteinase, papain and are grouped
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together into the papain superfamily (Rawlings and Barrett, 1993, 
Neurath,1989, Bond and Butler, 1987) The sequences of these enzymes 
are divided into three regions, two of which are highly conserved These two 
highly conserved regions are the amino-terminal or cysteinyl active site 
region and the carboxy terminal or histidine active site region The amino 
terminal region contains the cysteine rich site with the amino acid sequence, 
NH2-C-G-S-C-W-COOH This five amino acid motif is conserved among all 
members of the papain superfamily The third or central region is not as 
conserved as the other two regions
Despite some similarities, these enzymes may be differentiated and 
assigned to a particular class Table 1 1 shows all the different types of 
cathepsins characterised to date compared according to their type of 
activities, substrate specificities, molecular weights, isoelectric points and 
pH optima There are ten different classes of lysosomal cathepsin enzyme 
characterised to date (cathepsins B, D, E, H, J, L, M, N, S and T) The best 
charactensed cathepsins are cathepsin B, H, L and S Cathepsins J, M, N 
and T are the least well charactensed enzymes and they have as yet not 
been assigned enzyme classification (EC) numbers
Point mutation studies of cloned lysosomal cysteine proteinases 
showed that the substrate specificity of these enzymes resides in the S2 
subsites of their active sites (Schecter and Berger nomenclature, Schecter 
and Berger, 1967, Bromme e t a l ,  1994) For example, a single amino acid 
substitution (glycine to alanine) within position 133 of the S2 site caused the 
specificity of cathepsin S to change to cathepsin L- activity (Bromme e ta l., 
1994) Another amino acid substitution (phenylalanine to glutamate) in 
position 205 changed the specificity from cathepsin S-like to B-like (Bromme
9
e t a l ,  1994)
In the sections below the properties of each class of these enzymes 
will be discussed
10
Figure 1.2
Schematic representation of the general acid-general base catalytic 
mechanism of the aspartic peptidase type of enzyme
Breakdown of the tetrahedral intermediate gives a product complex 
containing both halves of the substrate, and this scheme indicates that 
dissociation of either can follow to give an acyl product complex or an amino 
product complex. (Taken from Dunn, 1989)
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Figure 1.3
Schematic representation of the catalysis of peptide bond cleavage earned 
out by a member of the metallo-peptfdase class of enzyme (Taken from 
Dunn, 1989)
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Figure 1.4
Schematic representation of the steps involved in catalysis by the cysteine 
peptidase type of enzyme
The catalytic Cys is involved in a tautomeric equilibrium between the neutral 
and zwitteriomc forms. It is believed that the anionic sulphur is involved in 
direct nucleophilic attack on the substrate carbonyl This scheme represents 
only the reaction through the acyl enzyme intermediate. Breakdown of that 
again involves enzyme-catalysed attack of water (Taken from Dunn, 1989)
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TABLE 1.1
The mammalian cathepsins The properties of each type of enzyme is 
summarised below
Class Type
of
activity
Preferred
substrate
pH
optimum
PI Mol.
Wt
(kDa)
B cys Z-arg-arg-NHMec 6 5-5.2 30*
D asp haemoglobin 3 5 5.5-7. 5 50*
E asp albumin 2.5 n.d. 100
H cys H-arg-NHMec 6.8 6-7 28*
J cys gly-arg-NNap 5-7.5 5.7 160
L cys Z-phe-arg-NHMec 4.5-6 5-6.3 _ _ ★ 30
M cys aldolase 5-7 n.d. 30
N cys collagen 3.5 6.2 34
S cys Z-val-val-arg-NHMec 6-7.5 7 24
T cys TAT,azocasein 6 n.d. 35
■k
Denotes molecular weight of heavy plus light chains 
n d Not determined
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Cathepsin B is the most abundant lysosomal cysteine proteinase 
present in mammalian tissues (Barrett and Kirschke, 1981) Cathepsin B has 
been purified from human liver (Barrett, 1973), calf liver (Snellman, 1969), 
bovine spleen (Ethenngton, 1974), rabbit skeletal muscle (Okitam e t a l ,
1988) and rabbit spleen (Maciewicz and Etherington, 1988)
The cDNA encoding human and mouse cathepsins B has been 
cloned and sequenced (Chan ef a / , 1987) It was found that the cDNA 
sequences of procathepsins B of mouse, human and rat were relatively 
highly conserved with a minimum of 68% sequence identity (Chan e t a l , 
1987) The amino acid sequences of cathepsin B, H, L and papain were 
compared by Dufour (1988) It was observed that rat cathepsin B was 31 5% 
homologous to rat cathepsin H, 32 % homologous to avian cathepsin L and 
30% homologous to papain (Dufour, 1988)
From the results of protein purification and cDNA cloning studies it is 
now known that mammalian cathepsin B is composed of two chains, a heavy 
chain of 25 kDa and a light chain of 5 kDa (Mason, 1991). A single-chain 
enzymatically active enzyme of 29 kDa can coexist with the two chain 
molecule (Barrett and Kirschke, 1981) Human cathepsin B has different 
isoforms with pi values in the pH 4 5-5 5 range The predominant isoform 
has a pi of 5 0-5 2 (Barrett, 1977) Cathepsin B is a glycoprotein but it does 
not bind Concanavalin A-Sepharose (Barrett and Kirschke, 1981)
Cathepsin B was found from amino acid sequencing to have one potential 
glycosylation site (Meloun e t a l , 1988)
Recent studies of rat cathepsin B show that it is synthesised as a
1.2.1 CATHEPSIN B (EC 3.4.22.1)
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precursor of 39 kDa and then processed to a single chain form of 29 kDa and 
eventually processed to the stable two chain form (Hara e t  a l , 1988, 
Nishimura e t a l , 1988, Mach e t a l , 1993,1994a,1994b) It was originally 
thought that cathepsin D catalysed the conversion of cathepsin B to the 
mature form (Nishimura e t a l , 1988) Hara e t  a l , (1988) found that the 
processing and activation of cathepsin B to the single chain form was halted 
by metalloproteinase inhibitors and the conversion of the single chain to the 
two chain form was stopped by the cysteine proteinase inhibitor E-64-d 
Experiments by Rowan e t a l  (1992) using cloned procathepsin B expressed 
in yeast showed that cathepsins D and L as well as mature cathepsin B can 
produce a processed (single-chain) form of the enzyme from its proenzyme 
More recent experiments on recombinant cathepsin B found that its 
proenzyme form was dependent on the processed active enzyme for 
maturation and activation (Mach e t a l ,  1993,1994a, 1994b)
The usual assay for cathepsin B is the synthetic fluorogemc peptidyl 
substrate Z-arg-arg-NHMec because the enzyme is active towards synthetic 
substrates containing arginine in the P-| position (Barrett and Kirschke,
1981) Cathepsin B cleaves protein substrates in vitro such as fibrinogen 
(Gabrijelcic e t a l , 1988), collagen (Ethenngton, 1974), haemoglobin, 
azocasein, proteoglycans, gelatin, IgG and bacterial cell wall proteins 
(Barrett, 1977). The pH optimum for cathepsin B on most substrates is pH 6 
(Barrett, 1972, Snellman, 1969) Cathepsin B is inactivated at alkaline pHs 
(Barrett and Kirschke, 1981)
From studies of its enzyme activity it was found that cathepsin B has 
the unusual property among the cathepsin enzymes of acting both as a 
peptidyldipeptidase and an endopeptidase enzyme depending on its
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substrate For example, human cathepsin B digests the B chain of insulin at 
10 endoproteolytic points of cleavage within the polypeptide but cleaves 
dipeptides from the C-terminus of both glucagon and rabbit muscle fructose- 
1,6-bisphosphate aldolase (Bond and Butler, 1987). Koga e t a l  (1991) 
investigated the pH dependence of the cathepsin B exo- and endo- 
peptidase activities and found that the exopeptidase activity showed a broad 
substrate specificity and pH optimum at pH 4-6 while the endopeptidase 
activity had a sharp pH optimum at pH 6 and showed a preference for 
substrates with basic amino acid residues in their P-| sites
Cathepsin B plays a role in both normal metabolic processes For 
example cathepsin B has been found to process human prorennm to its 
active form (Wang e t a l , 1991). Renin is the rate limiting enzyme in the 
generation of angiotensin II which is a major determinant of blood pressure 
and intravascular volume Therefore cathepsin B in processing of prorennm 
plays a role in blood pressure and intravascular volume regulation (Wang e t  
a l ,  1991).
Thyroid hormones play an important role in the regulation of 
metabolism The thyroid hormones form at discrete sites within the 
prohormone thyroglobulin (Dunn et  a l , 1991) Cathepsin B along with 
cathepsins D and L process thyroglobulin to release the thyroid hormones by 
a complex synergistic process (Dunn e t a l , 1991)
Cathepsin B is also implicated in tumour growth and invasion 
Cathepsin B-like enzymes are released extracellularly by neoplastic 
epithelial cells (Olstein and Liener, 1983) Sloane e t a l  (1982) have reported 
that a close correlation exists between the cathepsin B activity of variants of a 
murine melanoma tumour and their metastatic potential Kobayashi e t al.,
17
(1991) demonstrated that cathepsin B activated the tumour cell receptor- 
bound form of the proenzyme urokinase-type plasminogen activator (pro- 
uPA) The presence of uPA activity is associated with the invasive potential 
of tumour cells
1.2.2 CATHEPSIN D (EC 3.4.23.5)
Cathepsin D, is a lysosomal aspartic proteinase This enzyme was 
purified from both porcine and bovine spleens by conventional purification 
methods (Takahashi and Tang, 1981)
Cathepsin D can be separated by isoelectric focusing into five iso­
enzymes (I to V) with pis ranging from pH 5 5-7 5 Iso-enzymes l-IV are two 
chain enzymes of 50 kDa (35 kDa heavy chain, 15 kDa light chain) Iso­
enzyme V is a 100 kDa protein known as high molecular weight (HMW) 
cathepsin D Bovine cathepsin D has two iso-enzymes (A and B) separable 
by isoelectnc focusing Isoenzyme A has a pi of 6 49 and isoenzyme B has 
a pi of 6 04 (Takahashi and Tang, 1981) Both A and B iso-enzymes are two 
chain proteins of 46 kDa (34 kDa heavy chain, 12 kDa light chain)
Cathepsin D is a glycoprotein that binds to the lectm affinity resin 
Concanavalin A-Sepharose (Takahashi and Tang, 1981)
The proteolytic activity of cathepsin D is monitored by the cleavage of 
acid denatured haemoglobin at pH 3.2 (Takahashi and Tang, 1981, Bond 
and Butler, 1987) Cathepsin D is also assayed using the synthetic renin 
substrate, tetradecapeptide (TDP) N^-asp-arg-val-tyr-ile-his-pro-phe-his- 
leu-leu-val-tyr-ser-COOH Angiotensin I (N-terminal,10 residues of TDP) is 
released and measured by radioimmunoassay (Takahashi and Tang, 1981)
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Cathepsin D may also be assayed using the pentapeptide substrate BL-arg- 
gly-phe-phe-pro-MBNA in a coupled assay where cathepsin D cleaves the 
peptide substrate to release phe-pro-MBNA which is subsequently cleaved 
by dipeptidylaminopeptidase II, to release the chromophore MBNA (Ryvnyak 
e t a l ,  1990)
Cathepsin D plays a role in the processing of mature acid 
phosphatase in the lysosomes (Tanaka e t a l , 1990) Alkaline phosphatase 
is transported from the site of its synthesis in the endoplasmic reticulum via 
the Golgi complex to lysosomes as a membrane-bound enzyme , and is 
released form the lysosomal membranes into the lysosomal matrix in soluble 
form due to the action of the proteinase (Tanaka e t a l , 1990)
■ Cathepsin D is implicated in liver cirrhosis because it has the ability to 
cleave collagen and other components of the extracellular matrix (Ryvnyak 
e t a l  1991) Using electron histochemistry, Ryvnyak e t a l  (1991) found that 
cathepsin D was secreted by liver cells into the intracellular space dunng the 
course of this disease
1.2.3 CATHEPSIN E (EC 3.4.23.34)
Little information is known about cathepsin E. It is similar to 
cathepsin D in that it is a lysosomal aspartic proteinase It has a molecular 
weight of 100 kDa and a pH optimum of 2 5 Its usual assay substrate is 
albumin (Bond and Butler, 1987) Cathepsin E is found in bone marrow 
polymorphonuclear leukocytes and macrophages It has a high molecular 
weight for a lysosomal cathepsin enzyme and may be dimeric (Bond and 
Butler, 1987)
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1.2.4 CATHEPSIN H (EC 3.4.22.16)
The lysosomal cysteine proteinase cathepsin H, like cathepsins B, L 
and S has been extensively studied Cathepsin H has been purified from 
human liver (Barrett and Kirschke, 1981) and human kidney (Popovic etal . ,  
1993) using conventional chromatographic methods
Rat kidney cathepsin H was cloned and the sequence of its cDNA was 
determined (Ishidoh e t a l , 1987a) From the deduced amino acid 
sequence, cathepsin H was 44% homologous to cathepsin L and 30% 
homologous to papain Certain residues in the pro-peptide region of 
cathepsin H were sequenced and found to be highly homologous to the 
sequences of other cysteine proteinases (Ishidoh etal . ,  1987a)
Cathepsin H is synthesised as as a high molecular weight form 
(procathepsin H) of 41 kD, transported to the lysosomes and subsequently 
processed by proteolytic cleavage to a single chain molecule of 28 kDa 
(Hara e t a l , 1988) It may be eventually processed to the two chain form with 
a heavy chain of 23 kDa and a light chain of 5 kDa (Hara e t a l ,  1988) 
Cathepsin H is a glycosylated protein as it binds Concanavalin A-Sepharose 
(Barrett and Kirschke, 1981) From the results of molecular cloning of 
cathepsin H cDNA it was found that it possesses two potential glycosylation 
sites (Ishidoh e t a l , 1987a)
Cathepsin H isolated using conventional chromatographic methods 
was found to have a molecular weight of 28 kDa Human liver cathepsin H 
has two isoforms of pi 6 0 and 6 4 (Barrett and Kirschke, 1981) Affinity 
purified human kidney cathepsin H has two isoforms of pi 6 1 and 6 3 with 
molecular weights of 30 kDa (Popovic e t a l , 1993) Rabbit lung cathepsin H
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has several isoforms in the range 5 8-6 5 and the rat liver enzyme has a pi of 
7 1 (Barrett and Kirschke, 1981) In order to assay for cathepsin H, either the 
unblocked fluorogemc peptide arg-NHMec or the blocked fluorogemc 
substrate Z-arg-NHMec may be used because cathepsin H has the unusual 
property in that it can act both as an endopeptidase and an aminopeptidase 
in vitro (Barrett and Kirschke, 1981) When the enzyme is tested against 
synthetic substrates it has a pH optimum of pH 6 8 but is more active at pH 5- 
6 against azocasein (Barrett and Kirschke, 1981)
1.2.5 CATHEPSIN J
Cathepsin J is a high molecular weight (160 kDa) lysosomal cysteine
proteinase (Nikawa e t a l , 1992) consisting of two subunits a and (3 The a
subunit is a glycoprotein of 19-24 kDa and the (3 subunit, which is also a 
glycoprotein, has a molecular weight of 17 kDa
Cathepsin J was purified to homogeneity from the mitochondrial- 
lysosomal fraction of rat liver by acid treatment, ammonium sulphate 
precipitation, cation exchange chromatography, lectin affinity 
chromatography, organomercurial agarose affinity chromatography, anion 
exchange HPLC and size exclusion HPLC (Nikawa e t a l ,  1992) Isoelectric 
focusing of purified cathepsin J following treatment with sialidase to remove 
carbohydrate groups resulted in the protein focusing as two bands with pi 
values of 5 7 and 5 8
Following purification the N-terminal amino acid sequence of both 
subunits of cathepsin J were determined The N-terminal ammo acid
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sequence of the a subunit was very similar to the sequences of rat 
cathepsins B, H and L The sequence of the (3 subunit was not similar to 
other cathepsins
Cathepsin J is stable at slightly acid pHs but has a broad pH range of 
5 to 7 5 showing especially high activity at pH 7 5 It cleaves the 
endopeptidase fluorogemc substrate Z-phe-arg-NHMec in preference to Z- 
arg-arg-NHMec and arg-NHMec It also cleaves the exopeptidase 
substrates gly-arg-NHNap, ala-ala-NHNap and gly-phe-NHNap Cathepsin 
J, therefore exhibits dipeptidylaminopeptidase activity as well as 
endopeptidase activity
Antiserum against rat liver dipeptidylaminopeptidase I reacted with rat 
cathepsin J The cysteine proteinase specific inhibitor E-64 was not as 
effective at inhibiting both cathepsin J and dipeptidylpeptiase I compared to 
cathepsins B, H and L Therefore, cathepsin J shares some similarities to 
dipeptidylaminopeptidase I (Nikawa e t a l , 1992)
1.2.6 CATHEPSIN L (EC 3.4.22.15)
Cathepsin L is one of the most powerful lysosomal proteinases when 
assayed against protein substrates (Bond and Butler, 1987) It cleaves 
extracellular matrix proteins such as collagen and elastin, even more 
efficiently than collagenase and neutrophil elastase (Mason, 1991) It also 
cleaves azocasein, insulin B-chain, glucagon, histones and haemoglobin 
(Barrett and Kirschke, 1981, Kirschke e t a l , 1982, Kargel e ta l., 1980)
Cathepsin L has been extensively purified and characterised from a 
wide variety of mammalian sources such as human liver (Mason e t a l ,
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1985), rat liver (Kirschke e t a l , 1977, Bando e t a l , 1986, Kirschke e t  a l , 
1982), rabbit liver (Mason e t a l , 1984), mouse fibroblasts (Mason e t  a l ,
1987) and chicken liver (Dufour e t a l , 1987) The pro-form of mouse 
fibroblast cathepsin L has also been purified (Gal and Gottesman, 1986)
The cDNA encoding rat cathepsin L (Ishidoh e t al., 1987b), mouse 
pro-cathepsin L (Troen e t a l , 1987, Portnoy e t a l ,  1986), human pro- 
cathepsin L (Gal and Gottesman, 1988) and human cathepsin L (Chauhan 
e t a l , 1993) have been isolated and sequenced
It was found that rat cathepsin L shared 45 and 25% amino acid 
identity with rat cathepsins H and B respectively which was in agreement 
with the previous results of homology using direct amino acid sequencing 
(Ishidoh e t a l , 1987b)
Gal and Gottesman (1988) cloned and sequenced the cDNA 
encoding the major excreted protein from malignantly transformed mouse 
fibroblasts They found that it was the pro-form of cathepsin L as it exhibited 
98% N-termmal amino acid sequence similarity with human cathepsin L 
directly sequenced from purified protein by Mason e t a l  (1986) Sequencing 
analysis of the cDNA encoding the major excreted protein (MEP) of 
malignantly transformed mouse fibroblasts (Troen e ta l., 1987) and a mouse 
cysteine proteinase (Portnoy e t a l , 1986) identified the protein as the same 
molecule, mouse pro-cathepsin L It was found that this protein was 48% 
homologous to rat cathepsin H (Portnoy e t a l , 1986 ) and 80% homologous 
to human cathepsin L (Troen et  a l , 1987)
Chauhan e t a l  (1993) cloned human cathepsin L and found that there 
were two forms of this protein expressed from two distinct mRNAs in certain 
cancer cell lines These two mRNAs were encoded for by a single gene
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which they mapped to chromosome 9q21-22
Recombinant human cathepsin L has been expressed in the 
bacterium Escherichia coli (Smith and Gottesman, 1989) Deletion mutation 
experiments demonstrated that the enzyme needs the pro-peptide region for 
proper folding of the expressed protein and that the disulphide bond 
between the heavy and light chain of cathepsin L was found to be necessary 
for enzyme activity
Cathepsin L is synthesised in the rough endoplasmic reticulum as a 
pre-pro-form, subsequently transported to the Golgi stack as an inactive pro­
form of 39 kDa and finally translocated to the lysosomes of the rat liver 
(Nishimura e t a l , 1988) or macrophages (Hara e t a l , 1988) where it is 
processed to the single chain active form of 29 kDa It is thought that 
cathepsin D (Nishimura e t a l , 1988) or a metal chelator sensitive enzyme 
(Hara e t a l , 1988) are responsible for removal of the pro-peptide Cathepsin 
L is finally processed to the two chain form of the enzyme by the lysosomal 
cysteine proteinases (Hara e t  a l , 1988) The two chain enzyme is composed 
of a heavy chain of 25 kDA and a light chain of 5 kDa (Mason e t a l , 1986), or 
19 1 kDa and 4 8 kDa when the molecular weight values of the carbohydrate 
groups are omitted from the calculations (Wada e t a l , 1987)
From the results of purification studies cathepsin L has a pi of 5 8- 
6 1 (Barrett and Kirschke, 1981) Mason e t a l  (1984) found multiple forms of 
rabbit cathepsin L with pis from 5-5 9 Multiple forms of human cathepsin L 
also exist with pis from 5 7-6 3 (Mason et  a l , 1985)
Cathepsin L is a glycoprotein with an affinity for concanavalin A- 
Sepharose (Barrett and Kirschke, 1981) Cloning studies showed that 
cathepsin L has two potential N-glycosylation sites in its heavy chain
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(Ishidoh e t a l  ,1987b)
Enzyme kinetic studies of purified cathepsin L using synthetic 
fluorogemc substrates show that it has a preference for hydrophobic amino 
acid residues in the P2 position (Barrett and Kirschke, 1981) Cathepsin L 
cleaves the synthetic substrate Z-phe-arg-NHMec but not the cathepsin B 
specific substrate Z-arg-arg-NHMec or the cathepsin H specific substrate 
arg-NHMec (Mason e t a l , 1984,1985, Barrett and Kirschke, 1981) The 
diazomethylketone inhibitor Z-phe-phe-CHN2 is specific for cathepsin L 
(Bond and Butler, 1987, Barrett and Kirschke, 1981)
Cathepsin L is known as the most unstable lysosomal cysteine 
proteinase at neutral or alkaline pH (Barrett and Kirschke, 1981, Turk e t a l ,
1993, Mason e t a l , 1985) The pH optimum for cathepsin L on fluorogemc 
peptide substrates is in the pH 4 5-6 0 range (Dufour e t  a l , 1987, Mason e t  
a l ,  1984,1985, Kirschke e t a l ,  1977)
Cathepsin L may play a role in disease states such as cancer. The 
secretion and expression of cathepsin L has been shown to be induced by 
malignant transformation, growth factors and tumour promoters (Chauhan e t  
a l , 1993) Cathepsin L, if secreted may help tumour cells to metastasise as it 
cleaves a wide vanety of protein substrates (Mason, 1991) Secreted 
cathepsin L may further cause extracellular matrix degradation by its 
activation of a-|-proteinase inhibitor which normally regulates neutrophil 
elastase (Mason, 1991)
1.2.7 CATHEPSIN M
Cathepsin M is a lysosomal cysteine proteinase which can be
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Vdistinguished from the other cysteine proteinases on the basis of its substrate 
specificity and sensitivity to inhibitors such as antipain, elastinal, chymostatin 
and leupeptin (Pontremoli e t a l , 1982, Bond and Butler, 1987) Cathepsin M 
was purified from the soluble fractions of rabbit liver lysosomes using a 
combination of gel filtration chromatography and cation exchange 
chromatography (Pontremoli e t a l , 1982)
Cathepsin M has a molecular weight of approximately 30 kDa and is 
active in the pH 5-7 range Cathepsin M catalyses the limited modification 
and inactivation of fructose 1,6-bisphosphate aldolase (Pontremoli e t a l ,
1982)
A high proportion of cathepsin M (50%) is associated with lysosomal 
membranes which distinguishes this enzyme from the other lysosomal 
cysteine proteinases which are ‘soluble’ within the lysosome (Pontremoli et  
a l ,  1982)
1.2.8 CATHEPSIN N
Cathepsin N is a lysosomal cysteine proteinase of 34 kDa which is 
similar m activity to cathepsin L (Bond and Butler, 1987) This enzyme 
cleaves N-terminal peptides of native collagen and is sometimes termed 
‘collagenolytic cathepsin’ (Bond and Butler, 1987)
Cathepsin N was separated from cathepsins B, H, L and S present in 
Triton X-100 extracts of rabbit spleens using ammonium sulphate 
precipitation, ion-exchange chromatography, gel-filtration chromatography, 
hydrophobic interaction chromatography and isoelectric focusing (Maciewicz 
and Etherington, 1988)
Cathepsin N was found to cleave Z-phe-arg-NHMec better than Z-arg-
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arg-NHMec and arg-NHMec but it could be distinguished form cathepsin L 
on the basis of Bz-phe-val-arg-NHMec cleavage Cathepsin N cleaves Bz- 
phe-val-arg-NHMec slightly better than Z-phe-arg-NHMec while cathepsin L 
cleaves Z-phe-arg-NHMec 20 times better than Bz-phe-val-arg-NHMec 
(Maciewicz and Ethenngton, 1988) Cathepsin N has a pH optimum of 3 5 
and a pi of 6 2
Cathepsin N cleaves the collagen a chain with a similar activity to 
cathepsin L Both cathepsins S and B do not cleave collagen as well as 
cathepsins L and N (Maciewicz and Etherington, 1988) In terms of protein 
hydrolysis, cathepsin N may be distinguished from cathepsin L as it has little 
activity against azocasein (Bond and Butler, 1987)
1.2.9 CATHEPSIN S (EC 3.4.22.27)
Cathepsin S shares characteristics in common with cathepsin L such 
as its high endopeptidase activity with native protein substrates (Bond and 
Butler, 1987, Wiederanders e t a l ,  1992)
Cathepsin S was isolated from bovine (Kirschke e ta l., 1986) and 
rabbit spleens (Maciewicz and Etherington, 1988) using conventional 
chromatographic methods
The amino acid sequence of bovine spleen cathepsin S was 
determined using a combination of direct peptide sequencing and cDNA 
cloning (Wiederanders e t a l , 1991) Amino acid sequence identities of 
bovine cathepsin S to human cathepsins L, H and B are 56%, 47% and 31% 
respectively Cathepsin S also shares 41% identity with papain
Human cathepsin S cDNA has been cloned and sequenced The 
deduced cDNA sequence of the cathepsin S cDNA shares 85% similarity
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with bovine cathepsin S, 57% with human cathepsin L , 41% with cathepsin 
H and 31% with cathepsin B (Wiederanders et  a l , 1992)
Although cathepsins L and S are closely related molecules, they can 
be distinguished from each other on the basis of their enzyme activities 
Cathepsin S is stable at pH 7 while cathepsin L is not (Kirschke e t a l , 1989, 
Bromme e t  a l , 1989) Cathepsin L is more sensitive than cathepsin S to 
inhibition by the peptide inhibitor, Z-phe-phe-CHN2 (Bond and Butler, 1987) 
Cathepsin S is more sensitive to the inhibitor Z-phe-ala-CHN2 than 
cathepsins L or B (Bromme e t a l , 1989) Cathepsins L and S can be 
distinguished from each other from their different ratios of cleavage of Z-phe- 
arg-NHMec and Bz-phe-val-arg-NHMec (Bromme e t a l , 1989)
Punfied cathepsin S is a single chain protein unlike cathepsins B,H 
and L (Wieranders e t a l , 1991) Bovine spleen cathepsin S has a molecular 
weight of 24 kDa, a pi of 7 0 and a pH optimum on synthetic substrates of pH 
6-7 (Kirschke et  a l , 1989) Rabbit spleen cathepsin S is a protein of 30 kDa 
with a pi of 6 8 (Maciewicz and Ethenngton, 1988) Experiments using lectin 
affinity chromatography showed that cathepsin S is glycosylated as the 
protein was retained on these columns (Kirschke e t a l , 1989)
A cDNA encoding human lysosomal cathepsin S has been expressed 
in yeast (Bromme e t a l , 1993) The recombinant enzyme was processed in 
vitro to yield an active mature enzyme of 24 kDa The punfied enzyme had a 
pH optimum of 6 5 and an isoelectric point of between pH 8 3 and 8 6 which 
was about 1 5 pH units higher than for the bovine enzyme Kinetic substrate 
data revealed a preference for smaller amino acid residues in the binding 
subsites S2 and S3 of cathepsin S Like the bovine enzyme, recombinant 
cathepsin S is characterised by a broader range of pH stability (pH 5-7 5)
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than cathepsins B or L
1.2.10 CATHEPSIN T
Cathepsin T from rat liver is a lysosomal cysteine proteinase of 35 kDa 
and pH optimum of 6 (Bond and Butler, 1987) It can be distinguished from 
the other lysosomal cysteine proteinases by its ability to act on tyrosine 
aminotransferase (Bond and Butler, 1987)
1.3 PARASITIC CATHEPSINS
The presence of cathepsin-like proteinases have been recorded for 
many parasites The best characterised of these enzymes have been studied 
in trematodes such as Fasciola hepatica  and S ch isto so m a  m a n so m  and the 
protozoan parasites from the Trypansoma spp However, other parasites 
possess these enzymes
Mammalian cathepsin enzymes have been shown to degrade 
molecules which make up connective tissue, haemoglobin, fibrinogen and 
immunoglobulins, especially when secreted in disease states such as 
cancer Therefore, it is possible that similar molecules are involved in the 
pathogenesis of a number of parasitic diseases Parasite proteinases have 
been demonstrated to facilitate invasion of host tissues, allow parasites to 
digest host proteins, help them to evade the host immune response, and 
prevent blood coagulation (McKerrow, 1989) Therefore these proteins are 
important molecules in the study of parasitic diseases and have been 
proposed as potential targets for immunotherapeutic and chemotherapeutic 
reagents (McKerrow, 1989)
The best studied parasitic cysteine proteinases have been purified to
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homogeneity and have been characterised by enzymology studies and 
protein sequencing These proteinases have been shown to share 
enzymatic characteristics and sequence homologies with the mammalian 
cathepsins The majority of these proteinases share similarities with either 
cathepsins B or L.
In the following pages some of the better characterised parasitic 
cathepsin-like cysteine proteinases are listed However, it can be seen that 
there is less information about these molecules in comparison to their 
mammalian counterparts
Parasite ca thepsin  B-like e n zy m es
The best characterised parasitic cathepsin B-like enzyme has been 
studied from the trematode Sch istosom a m ansom , the causative agent of 
Bilharzia in humans This molecule of 31 kDa (Sm31) was shown to be the 
‘haemoglobinase’ previously described from adult S . m a n so m  (Felleisen 
and Klinkert, 1990, Gotz and Klinkert, 1993)
Lindquist e t a l  (1986) purified a cysteine proteinase from S m a n so m  
adult worms using a combination of gel filtration chromatography and 
chromatofocusing They found that the enzyme had different isoforms of 30- 
35 kDa depending on the preparation The enzyme degraded haemoglobin 
and had a preference for the cathepsin B peptide substrate Boc-arg-arg- 
NHMec
Chappell and Dresden (1987) purified a cysteine proteinase from 
media in which adult S. m ansom  worms were incubated The enzyme was 
isolated using a combination of gel filtration and immunoaffinity 
chromatography steps It was found to have a molecular weight of 32 kDa
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and to cleave the cathepsin B fluorogemc substrate CBZ-arg-arg-AFC The 
proteinase cleaved haemoglobin released from red blood cells and was 
activated by reduced glutathione present in sera and red blood cells 
Chappell e t a l  (1987)
This S m a n so m  cathepsin B-like enzyme described above has been 
cloned and its complete nucleotide sequence elucidated (Klinkert e t a l
1989) The inferred amino acid sequence showed extensive homology to 
mouse, rat and human liver cathepsins B
McGinty e t a l , (1993) showed, using novel active-site affinity labels, 
that adult and juvenile forms of the trematode parasite F h e p a tic a , the 
causative agent of liver fluke disease in mammals, possess cathepsin B-like 
enzymes of 25-26 kDa They also found that these F  hepatica  proteinases 
were stable under alkaline conditions, a charactenstic not shared with 
mammalian enzymes
Heussler and Dobbelaere (1994) confirmed the presence of F 
hepa tica  cathepsin B-like enzymes using cDNA cloning studies They found 
that this organism possess two cysteine proteinases which are related to 
mammalian cathepsins B
The swine parasitic nematode, Strongyloides ransom i was shown to 
have two cysteine proteinases which were extracted from the larval stage of 
the parasite at acid pH The pH optima of these enzymes was 4 8 and their 
molecular weights were 28 kDa and 32 kDa These enzymes were 
cathepsin B-like as they cleaved the substrate Z-arg-arg-NHMec (Dresden 
e t a l , 1985)
The nematode H aem onchus contortus, which is one of the most 
pathogenic endoparasites of sheep, has a cysteine proteinase termed AC-1
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which has been cloned and expressed from adult worms (Cox e t a l ,  1990) 
From the deduced amino acid sequence of almost full-length cDNAs of the 
proteinase, the enzyme was found to have a molecular weight of 35 kDa It 
was also determined that the proteinase displayed a 42% identity to human 
lysosomal cathepsm B which was more homologous to it than either 
cathepsins H or L Further studies showed that H contortus had 5 cysteine 
proteinases AC-1 to AC-5 which are all cathepsin B-like (Pratt e ta l., 1990, 
Pratt e t a l , 1992)
The human protozoan parasite, E ntam oeba histolytica causes 
dysentery, ulceration of the colon and invasion of the intestinal wall followed 
by metastasis to other organs This organism produces a cathepsin B-like 
enzyme (Lushbaugh e t a l , 1985) This proteinase was originally isolated 
from freeze-thaw extracts of E histolytica using a combination of lon- 
exchange chromatography, organomercunal agarose affinity 
chromatography and size exclusion chromatography (Lushbaugh e t a l ,
1985) The purified enzyme had a molecular weight of 16 kDa and cleaved 
the fluorogemc cathepsin B substrate Z-arg-arg-AFC
Luaces and Barrett (1988) punfied a cysteine proteinase from E. 
histolytica to homogeneity using a single step affinity chromatography 
method with an immobilised dipeptide The pure enzyme had a final 
molecular weight of 26 kDa It was claimed that this enzyme despite 
cleavage of Z-arg-arg-NHMec in preference to Z-phe-arg-NHMec was not 
cathepsin B-like due to kinetic and N-terminal sequence differences between 
it and mammalian cathepsin Bs and its stability at alkaline pHs For this 
reason, this proteinase was subsequently called ‘histolysin’
A cysteine proteinase isolated by Otte and Werries (1989) from E.
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histolytica homogenate using a combination of gel filtration chromatography, 
ion exchange chromatography and organomercurial agarose affinity 
chromatography, was found to be the same enzyme as that isolated by 
Luaces and Barrett (1988)
Molecular genetic studies of ‘histolysin’ were performed by Eakin e t  
a!., (1990) A 450 base pair fragment representing approximately 70% of 
the coding region of the enzyme was sequenced It was found that the 
predicted amino acid sequence of the enzyme was 45% homologous to 
chicken cathepsin L and 30 - 40% homologous to other eukaryotic 
cathepsins B or L which demonstrated that ‘histolysin’ belongs to the 
cathepsin family of cysteine proteinases This enzyme,was found in 
endosome-like vesicles found abundantly in amoeba cytoplasm which was 
analogous to the targeting of mammalian cathepsins L and B to lysosomes 
for intracellular protein degradation (McKerrow et al 1991)
Parasite ca thepsin  Ds
A cathepsin D-like proteinase has been purified and characterised 
from the parasitic nematode, Dirofilaria immitis (Swamy and Jaffe, 1983) 
This enzyme, referred to as Fp-ll had a molecular weight of 48 kDa and was 
purified using ion-exchange chromatography, ammonium sulphate 
precipitation and pepstatm agarose affinity chromatography The enzyme 
was active in the 2.6-3 4 pH range and was highly sensitive to pepstatin 
Bogtish and Kirschke (1987), demonstrated the possibility that the 
blood fluke, S ch is to so m a  japom cum  possess a cathepsin D-like proteinase 
by immuno-cytochemistry using antiserum raised to bovine cathepsin D as a 
probe for the enzyme
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A cathepsin D-like molecule was isolated from the avian malaria 
parasite, P lasm odium  lophurae  A combination of cation-exchange 
chromatography, affinity chromatography on pepstatin agarose and gel 
filtration chromatography were used to purify this molecule from 
haemoglobin-free parasite lysate (Sherman and Tamgoshi, 1983) The 
purified enzyme had a pH optimum of 3 5 against haemoglobin, a molecular 
weight of 32 kDa and a pi of 4 3 This enzyme digested membrane proteins 
and proteins from the cytoskeleton such as bands 1 and 2 (spectrin), bands 
2 1-26 (spectrin-binding proteins) and band 3 (Sherman and Tamgoshi,
1983)
Parasite ca thepsin  Ls
Cathepsin L-like enzymes are present in the trematode parasite 
Fasciola hepatica. These secreted liver fluke cysteine proteinases were 
originally shown to cleave IgG in a similar way to cathepsin B or papain 
(Chapman and Mitchell, 1982, Smith e t a l , 1993b, Carmona e t a l , 1993) 
Smith e t a l  (1993a) purified and characterised a cathepsin L-like 
enzyme from culture medium in which adult R  hepatica  were incubated 
They isolated the enzyme by using gel filtration and ion-exchange 
chromatography and demonstrated that the enzyme had a molecular weight 
of 27 kDa The enzyme was N-terminally sequenced and was found to share 
considerable homology with mammalian cathepsins L Antisera raised 
against the pure protein showed that the enzyme was located within vesicles 
of the gut epithelial cells of the liver fluke The same cathepsin L-like 
enzyme also degraded host IgG molecules (Smith e t a l  1993b, Carmona e t  
a l , 1993) and the proteinase prevented the antibody-mediated attachment of
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eosinophils to F  hepatica  larvae (Carmona e t a l , 1993)
A cysteine proteinase was isolated from adult F  hepatica  
homogenates using ion-exchange chromatography and molecular sieve 
HPLC (Rege e t a l , 1989) The molecular weight of the purified enzyme was 
14 5 kDa The enzyme had a pH optimum at pH 6 and it cleaved CBZ-phe- 
arg-AFC in preference to CBZ-arg-arg-AFC and CBZ-arg-AFC which 
indicated that the enzyme had cathepsin L-like rather than cathepsin H- or B- 
like activity
Yamasaki e t a l  (1989) isolated a cysteine proteinase of 27 kDa by 
ammonium sulphate precipitation, gel filtration and affinity chromatography 
on activated thiol-Sepharose A monoclonal antibody was raised against the 
purified protein and immunohistochemical studies using this monoclonal 
antibody located the enzyme to intestinal epithelial cells suggesting that the 
enzyme was secreted from the epithelial cells into the intestinal lumen to act 
as a digestive proteolytic enzyme The enzyme was subsequently cloned 
and was found to have a molecular weight, from the deduced amino acid 
sequence of 24 4 kDa (Yamasaki and Aoki, 1993) The amino acid 
sequence of the enzyme showed 50, 44 and 27% homology to mammalian 
cathepsins L, H, and B respectively
Cathepsin L-like enzymes (5 in total) from F hepatica  were cloned 
by Heussler and Dobbelaere (1994) One of these enzymes (called Fcp1) 
had a deduced molecular weight of 30 kDa From the amino acid sequence 
of this molecule, it was found that it shared homologies with human 
cathepsin L
Wijffels et at (1994) isolated cathepsin L-like isoenzymes from F 
hepatica  using a single step gel filtration protocol They found that the major
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isoenzyme had a molecular weight of 28 kDa and a pH optimum of 7 45 
This proteinase cleaved Z-phe-arg-NHMec but did not cleave Z-arg-NHMec 
It was subsequently cloned and from the deduced amino acid sequence of 
its cDNA, the proteinase was found to be similar to enzymes belonging to the 
cathepsin L subfamily but was less homologous to cysteine proteinases from 
S ch is to so m a , nematode cathepsins and the mammalian cathepsin B 
subfamily
Apart from the well characterised cathepsin B enzyme, adult 
S ch is to so m a  m a n so m  were also found to possess a cathepsin L-like 
enzyme (Smith e t al., 1994) Using fluorogemc substrates, they 
demonstrated that the enzyme had a preference for Z-phe-arg-NHMec over 
Z-arg-arg-NHMec and Bz-arg-NHMec Further evidence demonstrating that 
the enzyme was cathepsin L-like came from the deduced amino acid 
sequence of its cDNA The cDNA encoded a polypeptide of 24 kDa which 
was only 26%  homologous toS. m a n so m  cathepsin B but 46-47% 
homologous to cathepsins L from rat, mouse and chicken (Smith e t  a/,1994)
A neutral cysteine proteinase was characterised from the larvae of the 
helminth parasite Paragom m us w esterm am , the causative agent of the lung 
disease paragontmisis in humans (Yamakami and Hamajima, 1989, 
Hamajima e t a l , 1994) This enzyme was purified by a single step 
chromatography on a gel filtration column but the enzyme was fractionated 
not by molecular size but by its electrostatic behaviour on this 
chromatographic support (Yamakami and Hamajima, 1989) The enzyme 
had a molecular weight of 22 KDa and preferentially cleaved the fluorogemc 
substrate Boc-val-leu-lys-NHMec The enzyme was shown to have immuno­
suppressive properties and the deduced amino acid sequence from cDNA
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cloning studies showed that the enzyme was 20% homologous to cathepsin 
Ls, cathepsin Hs, chymopapain and papain precursor The percentage 
homologies were highest among the N-terminal regions The amino acid 
composition of this proteinase was shown to be most similar to cathepsin L 
(Hamajima e t a l , 1994)
The dog hookworm A ncylostom a canm um  is the causative agent of 
the allergic condition eosinophilic enteritis in humans This organism was 
shown by studies with the fluorogemc substrates Z-phe-arg-NHMec, Z-arg- 
arg-NHMec and Z-arg-NHMec to secrete a cathepsin L-like cysteine 
proteinase (Dowd e ta l., 1994)
The protozoan parasites of the Trypanosom a  spp which cause 
Chaga’s disease and sleeping sickness in humans possess cysteine 
proteinases which are similar to mammalian cathepsins L The best 
charactensed cysteine proteinase from trypanosomes is a molecule called 
cruzipain and was isolated from Trypanosoma cruzi
Cruzipain has been punfied to homogeneity from cell free extracts by 
a procedure involving ammonium sulphate precipitation, gel filtration, and 
ion-exchange chromatography (Cazzulo e t a l ,  1989)
The purified protein had a molecular weight of 60 kDa This protein 
was sequenced and was found to be homologous to cathepsin L (65% 
identity in 32 amino acids) The enzyme was located in lysosomes 
(Bontempi e t a l , 1989) and degraded IgG in vitro (Bontempi and Cazzulo,
1990)
Murta e t  a l , (1990) found that an antigen of 57 kDa from 7 cruzi was 
a cysteine proteinase closely related to cathepsin L using N-terminal 
sequencing and enzyme assays with the fluorogemc substrate Z-phe-arg-
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NHMec
The complete sequence of the gene encoding cruzipain was 
elucidated (Eakin e t a l , 1992), and the deduced ammo acid of the cDNA 
encoding the proteinase was determined The sequence of the protein was 
found to be most closely related to the sequence for T  brucei cysteine 
proteinase (59 3%) and mouse cathepsin L (42 2%) The deduced 
molecular weight of the protein was found to be 36 kDa which was 
considerably different to the molecular weight of 57-60 KDa found by 
Cazzulo e t al (1989) and Murta e t a l  (1990) for the same molecule 
Carbohydrate residues which were resistant to enzymatic hydrolysis were 
put forward as an explanation for the differences in molecular weights 
between the cloned molecule and the native protein (Eakin e t a l , 1992)
The African Trypanosome, Trypanosom a co n g o len se  was shown to 
possess a cathepsin L-like cysteine proteinase termed ‘trypanopain-Tc’ 
(Mbawa e t  a l , 1992) This enzyme was purified from lysosomal extracts 
using activated thiol-Sepharose affinity chromatography and gel filtration 
The enzyme had a molecular weight of 31-32 kDa by SDS-PAGE The 
proteinase hydrolysed the cathepsin L substrate Z-phe-arg-NHMec but did 
not hydrolyse cathepsin H or B substrates The enzyme was also shown to 
cleave fibrinogen, serum albumin and trypanosome-variant surface 
glycoprotein in vitro
A cysteine proteinase from Trypanosom a brucei has also been 
characterised and has found to be cathepsin L-like (Mottram e t a l , 1989, 
Robertson e t a l , 1990) From cloning and sequence analysis the deduced 
amino acid sequence of the T brucei cysteine proteinase shared 48% 
homology in the central region to human cathepsin L This homology was
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higher than either cathepsins B or H (Mottram e t a l , 1989) The cysteine 
proteinase from T brucei was also analysed using fluorogemc substrate 
SDS-PAGE and it was shown that the enzyme had inhibitor and substrate 
profiles similar to mammalian cathepsins L (Robertson e t a l , 1990)
Malaria parasites belong to the genus P lasm odium  and produce 
cathepsin L-like enzymes (Rosenthal e t a l , 1993, Rosenthal e t a l , 1989, 
Rosenthal e t a l , 1988) A Plasm odium  vinckei cathepsin L-like proteinase, 
which may be a haemoglobin degrading enzyme, was found to have a 
molecular weight of 27 kDa on zymograms containing gelatin Its pH activity 
optimum was found to be from pH 4-6 (Rosenthal e t a l ; 1993)
Plasm odium  falciparum  also produces a cathepsin L-like enzyme 
which may potentially degrade haemoglobin (Rosenthal e t a l ,  1989) From 
studies with fluorogemc substrates of extracts of trophozoites it was shown 
that the P falciparum  enzyme had a pH optimum in the 5 5-6 0 range and 
retained 50% of its activity at pH 7 (Rosenthal e t a l , 1989) From the results 
of enzyme kinetic studies it was shown that the enzyme favoured Z-phe-arg- 
NHMec over Z-arg-arg-NHMec and Z-arg-NHMec showing cathepsin L-like 
substrate specificity
Studies of the tick-transmitted, cattle protozoan parasite, Theilena  
parva  by molecular genetic studies and fluorogemc studies of parasite 
lysates (Nene e t a l , 1990), showed that this organism possessed a cysteine 
proteinase of 23 5 kDa which may be related to lysosomal cathepsins L 
found in other protozoan parasites (Lonsdale-Eccles and Grab, 1987, 
Rosenthal e t a l , 1989)
In conclusion, cathepsin-like proteinases have a wide distribution in 
the animal kingdom Because of their implied roles in the pathogenesis of
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disease, be that cancer or infectious diseases, these enzymes are of great 
medical importance The present study describes the isolation and 
characterisation of a cathepsin L proteinase from Fasciola hepatica, a 
parasitic helminth of mammals
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 MATERIALS
Bachem
H-gly-his-arg-pro-OH
H-gly-pro-arg-OH
H-gly-pro-arg-pro-OH
H-leu-val-tyr-NHMec
Suc-leu-leu-val-tyr-NHMec
Tos-gly-pro-lys*NHMec
Z-phe*ala-CHN2
Z-phe-arg-NHMec
Cambridge Research Biochemicals
Z-arg-arg-NHMec
Gibco Life Technologies Ltd.
RPMI-1640 (10X) without L-glutamine and Na2HC03
ICN Biomedicals Ltd.
Bovine fibrinogen (95% clottable)
Bovine thrombin (1147 NIH units/ml)
Pharmacia LKB Biotechnology
QAE Sephadex A50 
Sephacryl S200HR
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Pierce Chemicai Co.
BCA protein assay kit
Promega
Anti-rabbit IgG (Fc) alkaline phosphatase conjugate 
Agarose (molecular biology grade)
)
University of Cambrige protein sequencing facility
Polyvmylidinedifluonde (PVDF, Problott)
Schleicher and Schuell
Nitrocellulose (0 45 |im pore size)
Sigma Chemical Co.
Boc-val-leu-lys-NHMec 
Boc-val-pro-arg-NHMec 
Bz-arg-NHMec 
Bz-phe-val-arg-NHMec 
dithiothreitol (Cleland’s reagent)
E-64
Gentamicin
Freund's Complete and Incomplete Adjuvants
Gelatin
HEPES
Hirudin (650 U/mg)
Suc-ala-phe-lys-NHMec
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tetramtromethane (TNM)
Tos-gly-pro-arg-NHMec
2.2 SOURCE OF F A S C I O L A  HEPATI CA  CY STE IN E  
PROTEINASES
Mature F  hepatica  parasites were removed from the bile ducts of infected 
bovine livers obtained at a local abattoir The parasites were washed six 
times in phosphate buffered saline (PBS), pH 7 3, and maintained for 16 
hours in RPMI-1640, pH 7 3, containing 2% glucose, 30 mM HEPES and 25
mg/ml gentamicin at 37°C Following the incubation period, the culture
medium was removed, centrifuged at 14,900 x g  for 30 min and the
supernatant stored at -20°C (Dalton and Heffernan, 1989)
2.3 ENZYMATIC ASSAYS WITH FLUOROGENIC SUBSTRATES
Proteinase activity was measured fluorometrically using peptide-NHMec as
substrate Each substrate was stored as a 1 mg 100 pJ"1 stock solution in
dimethyl-formamide Assays were carried out using a final concentration of 
10 |iM substrate in 0 1 M glycine-HCI, pH 7, containing 0 5 mM dithiothreitol,
in a volume of 1 ml The mixtures were incubated at 37 °C  for 30 min before
stopping the reaction by the addition of 200 |il of 1 7 M acetic acid The 
amount of 7-amino-4-methylcoumarin (NHMec) released was measured 
using a Perkin-Elmer fluorescence spectrophotometer with excitation set at 
370 nm and emission at 440 nm One unit of enzyme activity was defined as
that amount which catalysed the release of one nmole of NHMec per min at
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2.4 PURIFICATION OF F A S C I O L A  HEPATIC A  CYSTEINE  
PROTEINASE
Five hundred ml of culture medium in which mature F hepatica  were 
maintained were thawed and concentrated to a volume of 10 ml in an 
Amicon 8400 concentrator using an Amicon YM3 membrane (3 kDa 
molecular weight cut-off, Amicon, Wl), and applied to a* Sephacryl S200HR 
gel filtration column (2 6 cm X 74 5 cm) equilibrated in 0 1 M Tris-HCI, pH 7,
at 4°C. The column was eluted with 0 1 M Tris-HCI, pH 7, and 5 ml fractions
were collected Each fraction was assayed for cathepsin L activity using the 
fluorogemc substrate Tos-gly-pro-arg-NHMec at a final concentration of 10 
|j.M in 0 1 M glycine-HCI, pH 7
The Sephacryl S200 fractions containing cathepsin L activity were pooled 
and applied to a 50 ml QAE Sephadex column (2 5 cm X 10 0 cm) 
equilibrated in 0 1 M Tns-HCI, pH 7 The QAE Sephadex column was 
washed with 300 ml of 0 1M Tris-HCI, pH 7, and then proteins eluted with 
150 ml of 75 mM NaCI in 0 1 M Tris-HCI, pH 7, and then 250 ml of 400 mM 
NaCI in 0 1 M Tris-HCI, pH 7 Five ml fractions (180 fractions total) were 
collected and assayed for cathepsin L activity using the fluorogemc substrate 
Tos-gly-pro-arg-NHMec The cathepsin L activity was pooled and then 
concentrated to 20 ml on an Amicon 8400 concentrator using a YM3 
membrane The concentrate was then diluted with distilled water to a volume 
of 100 ml and re- concentrated to a final volume of 10 ml to have a NaCI 
concentration of approximately 80mM The concentrated cathepsin L was
stored as 1 ml aliquots at -80°C
37°C
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2.5 SDS-POLYACRYLAMIDE GEL ELELCTROPHORESIS (SDS- 
PAGE)
Homogeneity of the purified cathepsin L2 was determined by denaturing 
SDS-PAGE gels containing 12% polyacrylamide using the buffers and 
methods described by Laemmli (1970)
2.6 ZYMOGRAPHY
Zymography was performed, both in the presence and absence of SDS, 
using 12% PAGE gels according to the method of Dalton and Heffernan 
(1989)
2.7 PROTEIN CONCENTRATION
Protein concentration was measured using a BCA protein assay kit in 
microtitre plates according to the method of Redinbaugh and Turley (1986) 
Bovine serum albumin was used as a protein standard.
2.8 AMINO-TERMINAL SEQUENCE ANALYSIS
Forty |il (40 |ig ) of concentrated culture medium in which mature F  hepatica  
were maintained were applied to a 12% SDS-PAGE gel and 
electrophoresed as described above After electrophoresis, the gel was 
incubated for 30 min in transfer buffer (25 mM Tris, 190 mM glycine and 10% 
(v/v) methanol) A PVDF membrane was immersed in methanol for 10 sec 
and then equilibrated in transfer buffer for 5 min The electrophoretically 
separated proteins were transferred to the PVDF membrane using a semi­
dry electroblotting apparatus (Atto Corp , Tokyo, Japan) according to the
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manufacturers instructions The membrane was stained in 0 1% Coomassie 
blue R in 50% methanol, 1% acetic acid for 5 min and destained for 5 min 
with 5 changes in 50% methanol, 10% acetic acid and then air-dried The 
protein of interest was sequenced on an Applied Biosystems 477A protein 
sequencer at the Biochemistry Department, University of Cambridge, UK
2.9 KINETIC STUDIES
The kinetic constants of the two purified F hepatica  cathepsin L proteinases 
were determined for 11 different substrates Z-phe-arg-NHMec, Bz-phe-val- 
arg-NHMec, Suc-leu-leu-val-tyr-NHMec, H-leu-val-tyr-NHMec, Tos-gly-pro- 
lys-NHMec, Tos-gly-pro-arg-NHMec, Boc-val-pro-arg-NHMec, Z-arg-arg- 
NHMec, Boc-arg-NHMec, Suc-ala-phe-lys-NHMec and Bz-val-leu-lys- 
NHMec The kinetic constants, kca tand Km, were obtained by non-linear 
regression analysis by using the program Enzfitter (Leatherbarrow, 1987)
2.10 ACTIVE SITE TITRATION OF CATHEPSINS L1 AND L2
Active site titration using the cysteine proteinase inhibitor L-trans- 
epoxysuccmyl-leucylamido-(4-guanido)-butane (E-64) was performed 
according to the method of Barrett e t a l  (1982) using the fluorogemc 
substrate Z-phe-arg-NHMec
2.11 DIRECT FLUOROGENIC SUBSTRATE ANALYSIS IN 
POLYACRYLAMIDE GELS
Culture medium in which mature F hepatica  were maintained was 
electrophoretically separated in non-denaturing 12 % polyacrylamide gels 
Following electrophoresis the substrate specificities of the two cathepsin L
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proteinases was examined by incubating replicate gels in different 
fluorogemc substrates This method was performed as described by 
Robertson e t a l  (1990) with the exception that SDS was not included in the 
gels The gels were first washed twice at room temperature in 0 1 M glycine, 
pH 7, before being transferred to 0 1 M glycine, pH 7, containing 10 mM
cysteine and 10 |iM of one the following substrates Z-phe-arg-NHMec, Boc-
val-leu-lys-NHMec, Tos-gly-pro-arg-NHMec and Tos-gly-pro-lys-NHMec The
gels were then incubated at 37°C for 15 min Fluorescent bands locating the
substrate cleaving enzymes within the gel were detected using a UVP 
Chromatovue model TM-20 UV-Transilluminator and recorded using a 
Polaroid camera fitted with a Kodak Wratten gelatin filter (model 2E)
2.12 NITRATION OF CYSTEINE PROTEINASES WITH 
TETRANITROMETHANE (TNM)
Proteins in the culture medium in which mature F  hepatica  were maintained 
and purified cathepsin L were modified by nitration with tetramtromethane 
(TNM) (Riordan and Vallee, 1972) The samples ( <20 jig) were incubated 
with varying concentrations of TNM (0 5 mM - 4 0 mM) in PBS, pH 7 3, and 
10% ethanol, for 1 hour at room temperature The effect of nitration on the 
activity of the cysteine proteinases was analysed by zymography in native 
non-SDS polyacrylamide gels
2.13 PREPARATION OF ANTIBODY TO CATHEPSIN L2
Polyclonal antiserum against cathepsin L purified in this study was prepared 
in New Zealand white rabbits An initial immunisation of 100 |ig of purified
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cathepsin L in Freund’s Complete Adjuvant was followed by 4 
immunisations, 4 weeks apart, of 100 |ig in Freund’s Incomplete Adjuvant
2.14 PREPARATION OF MATURE F A S C I O L A  H E P A TIC  A  EXTRACT
Mature F hepatica  were homogenised in 0 1 M Tris-HCI, pH 7, or in the
same buffer containing 1 mM EDTA, 5 ^ig/ml leupeptin, 1 mM
phenylmethylsulfonylfluoride (PMSF) and 4 mg/ml lodoacetamide, in a 
glass-glass hand homogemser Extracts were centrifuged for 10 min at 
14,900 x g  and the supernatant used in immunoblotting experiments
2.15 IMMUNOBLOTTING ANALYSIS
Mature F hepatica  extracts, culture medium in which parasites were 
maintained and the two purified cathepsin L proteinases were separated by 
reducing SDS-PAGE and electrophoretically transferred to nitrocellulose 
paper using a semi-dry electroblotting system (Smith e t a l , 1993a)
Following blocking in 0 5% bovine serum albumin and 0 1% Tween 20 the 
nitrocellulose membrane was incubated in anti-cathepsin L2 or non-immune 
rabbit serum Bound immunoglobulin was visualised using alkaline 
phosphatase-conjugated anti-rabbit serum Nitro-blue tetrazolium and 5- 
bromo-4-chloro-indolyl phosphate prepared in dimethylformamide were 
used as substrates for alkaline phosphatase (Smith e t a l , 1993a)
2.16 IN VITRO  CLOTTING ASSAY
F hepatica  cathepsin L2 (2 3 x10' 3 units) or bovine thrombin (5 7 x10"3 NIH 
units) was added to 100 \i\ of a 20 mg ml*1 solution of bovine fibrinogen in
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phosphate buffered saline (PBS) in 12x75 mm test tubes. Ten |il of 1 mM 
dithiothreitol in PBS was added to the tubes and the volume then adjusted to
150 jil with PBS. The tubes were incubated at 37°C and the time taken for
stable fibrin clots to form was recorded.
2.17 ELECTROPHORETIC ANALYSIS AND IMMUNOBLOTTING 
OF FIBRIN CLOTS
Fibrin clots were centrifuged at 15,000 x g  for 1 min. The supernatant was 
removed and clot was washed 5 times by adding 1 ml of PBS to the tubes 
followed by centrifugation at 15,000 x g  for 1 min. The clot was finally
resuspended in 100 |il reducing SDS-PAGE sample buffer and boiled for 2
min. Reducing 10% SDS-PAGE was performed according to the method of 
Laemmli (1970).
Immunoblotting studies of fibrin clots were performed as described in 
section 2.15.
2.18 FIBRIN PLATE ASSAY
Ten ml of 1% agarose , warmed to 50°C, was mixed with 9.5 ml of a 0.4% 
(w/v) fibrinogen solution (in PBS containing lOO^M dithiothreitol) which was
also heated to 50°C. Three ml of the fibrinogen-agarose mixture was applied
to a glass microscope slide (76 x 26 mm) add allowed to solidify. Wells of 
4mm diameter were cut into the fibrin-agarose plate. Aliquots (10,15 or 20 (il) 
of cathepsin L or thrombin were added to the wells in the fibrin-agarose
plate. The plates were then incubated for 5h at 37°C in a humid chamber.
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Following incubation the diameters of the ‘ hazy ' rings, formed due to the 
polymerisation of fibrin, were measured using a vernier callipers Results 
were also photographically recorded on Polaroid film In the inhibition
studies, hirudin (1 unit ml"1) and Z-phe-ala-CHN2 (600 |iM) were added to
the cathepsin L and thrombin samples prior to the addition of these to the 
fibrin-agarose plate wells
2.19 STUDIES OF FIBRIN CLOTS WITH PRIOR ADDITION OF 
FIBRIN ANTI-POLYMERANTS
The fibrin-anti-polymerants, H-gly-pro-arg-OH, H-gly-his-arg-pro-OH and H- 
gly-pro-arg-pro-OH were added to test tubes, at a final concentration of 75
|iM, containing fibrinogen (100 |oJ, 20 mg m l'1) and assayed for in vitro
clotting ability as described in section 2 16
2.20 STUDIES OF ENZYME ACTIVITY WITH PRIOR ADDITION 
OF FIBRIN-ANTI-POLYMERANTS AND PROTEINASE INHIBITORS
The fibrin anti-polymerants, H-gly-pro-arg-OH, H-gly-his-arg-pro-OH and H- 
gly-pro-arg-pro-OH and the cathepsin specific inhibitor Z-phe-ala-CHN2 
were added to enzyme assay mixtures at final concentrations of 75 and 300
|iM The thrombin-specific inhibitor, hirudin, was added to enzyme assay
mixtures at a final concentration of 1 unit ml' 1 Proteinase activity was
assessed using the fluorogemc substrate Tos-gly-pro-arg-NHMec as 
described in section 2 3
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2.21 POSITIONING OF THE CLEAVAGE SITE OF THROMBIN AND 
CATHEPSIN L2 ON FIBRINOGEN
Fibrinogen was incubated with thrombin (5 7 x 10' 3 NIH units) and 0, 200, 
250, 300, 350 or 400 |xM of the fibrinogen anti-polymerant, H-gly-pro-arg- 
pro-OH, and incubated for 100 min at 37 °C as descnbed in section 2 16
Thrombin or cathepsin L2 was subsequently added to replicate sets of assay 
tubes and the time taken for clot formation was recorded
After 60 minutes incubation, reducing SDS-PAGE sample buffer was 
added to the assay tubes containing 0, 200, 300 and 400 jxM anti- 
polymerant The samples were boiled and then analysed on 10% SDS- 
PAGE gels as described in section 2 5
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CHAPTER 3 
RESULTS PART 1 
Purification and characterisation of cathepsin L2 
from adult Fasciola hepatica
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3.1 PURIFICATION OF CATHEPSIN L2
F  hepatica  cysteine proteinase was purified by gel filtration on Sephadex 
S200 (Figure 3 1) followed by ion exchange chromatography on QAE 
Sephadex (Figure 3 2) The proteinase eluted from the gel filtration column 
in a broad protein peak together with another cysteine proteinase that has 
been isolated and characterised as a cathepsin L-like proteinase by Smith 
e t  a l (1993a), however, the two proteinases were separated by ion
<r
exchange chromatography on QAE Sephadex as the proteinase described 
by Smith e t al (1993a) did not bind to the column and was therefore carried 
in the column run-through The other cysteine proteinase activity binds to the 
column and was subsequently eluted with 400 mM NaCI
Analysis of the cysteine proteinase in the protein peak eluted at 400 
mM NaCI by zymography in the presence of SDS revealed that the enzyme 
migrates as four bands, four similarly migrating bands are also observed in 
the total culture medium in which mature F hepatica  were maintained 
(Figure 3 3A) In contrast, when the proteinase is analysed by zymography in 
the absence of SDS it migrates more slowly and as a single proteolytic band 
(Figure 3 3B) SDS-PAGE analysis, under reducing conditions revealed that 
the proteinase is homogeneous and migrates as a single band of 29 5 kDa 
on a reducing SDS-PAGE gel (Figure 3 3C) The cysteine proteinase was 
purified 150-fold from the F hepatica  culture medium by the two column 
procedure (Table 3 1) The cysteine proteinase represents a major protein in 
the culture medium (Figure 3 3C ) which would account for the relative ease 
by which the protein can be isolated The other major protein observed in the 
culture medium at 27 kDa represents the cathepsin L-like proteinase isolated 
by Smith e t al (1993a) The proteinase isolated in this study had a final
54
specific activity of 1 941 units mg' 1
The first 14 N-terminal amino acids of the purified cysteine proteinase were 
determined The N-terminal sequence, aligned with the N-terminal 
sequences determined for F  hepatica  cathepsin L isolated by Smith e ta l  
(1993a), is shown in Figure 3 4. Homologous amino acids are indicated by 
dots The N-terminal sequence of the cysteine proteinase isolated in the 
present study is almost identical to that of the cathepsin L isolated by Smith 
e t  aI (1994a) One ammo acid difference was observed, an arginine in 
position 7 in the cysteine proteinase isolated in this study is substituted for a 
proline in the cathepsin L sequence (Smith e t a l , 1993a)
The cysteine proteinase sequence is 47% homologous to the N-terminal 
region of chicken liver cathepsin L (Dufour e t a l , 1987), rat liver cathepsin L 
(Ishidoh e t a l , 1987b) and human liver cathepsin L (Mason e t a l , 1986) and 
40% homologous to the Trypanosoma cruzi cathepsin L-like proteinase 
(Cazzulo e t a l , 1989) The sequence is only 20% homologous to the 
cathepsin B of the related parasitic trematode, S ch isto so m a  m a n so m  
(Feilleisen and Klinkert, 1990) A feature that appears to be peculiar to the 
presently described F hepatica cysteine proteinase and the cathepsin L 
isolated by Smith e t al (1993a) is the presence of an extra alanine residue 
at the beginning of the N-terminal sequence
The N-terminal sequences of the F hepatica  cathepsms are 47% 
homologous to that of the bovine cathepsin L (Turk e t a l , 1985) and to a 
recently described cathepsin S (Wiederanders e t a l , 1991) Our enzyme 
kinetic studies (see below) are consistent with the classification of the two F
3.2 N-TERMINAL SEQUENCE ANALYSIS OF CATHEPSIN L2
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Vhepa tica  cysteine proteinases as cathepsin Ls To distinguish the two F 
hepa tica  cathepsin L proteinases, they have been designated cathepsin L1 
(27 kDa) (Smith e t a ! , 1993a) and cathepsin L2 (29 5 kDa)
3.3 IMMUNOBLOTTING STUDIES
Aqueous extracts of mature F hepatica  were prepared in the presence and 
absence of the proteinase inhibitors EDTA, leupeptin, 
phenylmethylsulfonylfluoride (PMSF) and lodoacetamide When these 
extracts were analysed and compared by reducing SDS-PAGE, it was 
observed that many proteins were degraded when the proteinase inhibitors 
were omitted (Figure 3 5, panel A, compare lanes 1 and 2) Other samples of 
these extracts were transferred, following reducing SDS-PAGE, to 
nitrocellulose filters which were subsequently probed with anti-cathepsin L2 
serum The anti-cathepsm L2 antibodies were reactive with two proteins 
corresponding to cathepsin L1 (27 kDa) and cathepsin L2 (29 5 kDa), the 
enzymes were not susceptible to proteolytic degradation in the extracts 
which did not contain proteinase inhibitors (Figure 3 5 panel B, compare 
lanes 1 and 2) When the mature F hepatica  culture medium, and cathepsin 
L1 and cathepsin L2 purified from this medium, were similarly analysed by 
immunoblotting it was observed that both cathepsin L1 and cathepsin L2 
were secreted as molecules of similar molecular size to the enzymes in the 
extracts of whole parasites (Figure 3 5, panel C)
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Figure 3.1
S ep h a cry l S20 0 H R  chrom atography o f ca thepsm  L2
The culture medium in which mature F. hepatica  were maintained (340 mg) 
was concentrated to 10 ml and applied to a Sephacryl S200HR column 
(2 6cm x 74 5cm) The mobile phase was 0 1M Tns-HCI, pH 7 Protein 
elution from the column was monitored by absorbance at 280 nm using a 
flow-through spectrophotometer Cysteine proteinase activity in collected 
fractions was assayed using the fluorogemc substrate Tos-gly-pro-arg- 
NHMec Fractions containing Tos-gly-pro-arg-NHMec were pooled (solid 
bar) and applied to a QAE-Sephadex column
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Figure 3.2
Q A E -S ep h a d ex  chrom atography o f ca thepsm  L2.
The S200HR pooled fractions (16 mg protein) were applied to a QAE- 
Sephadex column (2.5cm x 10cm) equilibrated in 0 1M Tris-HCI, pH 7 The 
column was washed with the same buffer and the cysteine proteinase was 
eluted with 400mM NaCI in 0 1M Tris-HCI, pH 7. Protein content was 
monitored at 280 nm. Enzyme activity in collected fractions was assayed 
using the fluorogenic substrate Tos-gly-pro-arg-NHMec and fractions 
containing activity were pooled (solid bar).
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A nalysis  o f  purified ca thepsm  L2 b y  zym ography a n d  reducing SD S-PAG E.
A  Zymograms performed in the presence of SDS Culture medium (20 ^g) 
in which mature F hepatica  were maintained ( Lane 1) and purified cysteine 
proteinase (2 5 ^g) were analysed by zymograms containing 0 1% SDS
B. Zymograms performed in the absence of SDS. Culture medium in which 
mature F  hepatica  were maintained (Lane 1) and purified cysteine 
proteinase were analysed by zymograms in the absence of SDS
C. Reducing SDS-PAGE analysis of punfied cathepsin L2 Culture medium 
in which mature F  hepatica were maintained (Lane 2) and purified cysteine 
proteinase (Lane 3) were analysed by SDS-PAGE under reducing 
conditions Lane 1, prestained molecular size markers (alpha2
macroglobulin,211 kDa; beta-galactosidase,119 kDa, fructose-6-phosphate 
kinase, 98 kDa; pyruvate kinase, 80 6 kDa, fumarase, 64 4 kDa; lactic 
dehydrogenase, 44 6 kDa; and tnosephosphate isomerase, 38 9 kDa)
Figure 3.3
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-1 1 2 3 4 5 8 7 8 9 10 11 12 13 14
F. hepatica (cathepsin L2) A V P 0 K 1 0  R R E S - - G Y V -
F. heoatlca (cathepsin L I) A V P D K 1 D P R E S - - G Y V T
Chicken liver (cathepsin L) - A P R S V D W R E K - - G Y V T
Rat liver (cathepsin L) * 1 P R S V D W R E K - - G Y V T
Human liver (cathepsin L) - A P R S V D W R E K - - G Y V T
Bovine liver (cathepsin L) - L P D S V D W R E K - G G V T
Bovine spleen (cathepsin S) - L P 0 S M 0 W R E K - - G C V T
l& U Zi (cruzipain) - A P A A V D W R A R * ■ G A V T
S.mansoni (cathepsin R) - 1 P s N F D S R K K W P G C K s
Figure 3.4
N -term m al am ino acid  s e q u e n c e  o f ca thepsin  L2.
The determined sequence (14 amino acids) is shown compared to the N- 
terminal sequence of F hepatica  cathepsin L1 (Smith eta l., 1994a) and 
cathepsin L from chicken liver (Dufour e t a l ,  1987), rat liver (Ishidoh e t a l ,  
1987b) and human liver (Mason e t a l , 1986) Also included for companson 
are the N-terminal sequences of bovine liver cathepsin L (Turk e ta l., 1985), 
bovine spleen cathepsin S (Wiederanders eta l., 1991), Trypanosom a cruzi 
cathepsin L-like proteinase (cruzipain) (Cazzulo e ta l., 1989) and 
S ch is to so m a  m ansoni cathepsin B (Feilleisen and Klinkert, 1990). 
Homologous residues are indicated by dots.
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Figure 3.5
Im m unoblotting experim en t with anti-cathepsm  L2.
A. Reducing SDS-PAGE analysis of PBS extracts of whole mature F. 
h ep a tica  parasites Parasites were extracted in the presence (lane 1) and in 
the absence (lane 2) of proteinase inhibitors Gels were stained with 
Coomassie blue R
B  Immunoblot analysis of parasite extracts. Mature F hepatica  proteins 
(120 ^g) extracted in the presence (lane 1) and absence (lane 2) of 
proteinase inhibitors were electrophoretically separated and transfered to 
nitrocellulose Nitrocellulose filters were then probed with rabbit antiserum 
prepared against cathepsm L2 No bands were visualised when control 
rabbit serum was used to probe duplicate blots (not shown).
C  Immunoblot analysis of culture medium and purified cathepsin L1 and 
cathepsm L2. Medium in which mature F  hepatica w ere maintained (10 ^g) 
(lane 1), purified cathepsm L1 (1 |ig) (lane 2) and purified cathepsm L2 (1 
(xg) ( lane 3 ) were electrophoretically separated and transferred to 
nitrocellulose Filters were then probed with rabbit antiserum prepared 
against the purified cathepsin L2 No bands were visualised when control 
rabbit serum was used to probe duplicate blots The molecular size markers
(prestained) were alpha2 macroglobulin, 211 kDa; beta-galactosidase, 119 
kDa, fructose-6-phosphate kinase, 98 kDa, pyruvate kinase, 80 6 kDa; 
fumarase, 64 4 kDa, lactic dehydrogenase, 44.6 kDa, and triosephosphate 
isomerase, 38 9 kDa
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Table 3.1
Purification of cathepsm L2
Step Protein
(mg)
Specific
Activity
(units)
Total
Activity
(units mg--*-)
Recovery
(%)
Purif­
ication
(-fold)
Culture
Medium
341.7 4 44 0 013 - 1
S200 16 4 1.68 0.102 38 7 .85
QAE400 0.68 1.32 ^ 1 941 29.7 149
* Enzyme activity was measured using the substrate 
Tos-gly-pro-arg-NHMec
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CHAPTER 4 
RESULTS PART 2 
Comparison of Fasciola hepatica 
cathepsm L1 and L2 activities
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Enzyme kinetic studies were earned out using purified F  hepatica  cathepsin 
L1 and cathepsin L2 Kinetic constants were obtained for eleven different 
fluorogemc peptide substrates including those that are classically used for 
the characterisation of cathepsin proteinases, namely, Z-phe-arg-NHMec, Z-
i
arg-arg-NHMec and Bz-arg-NHMec (Table 4 1 and Barrett and Kirschke,
i
1981) Both the F  hepatica  cathepsins L1 and L2 have a high affinity (kcat/ 
Km) for the substrate Z-phe-arg-NHMec and low affinity for the substrates Z- 
arg-arg-NHMec and Bz-arg-NHMec The preference for a hydrophobic
I
phenylalanine in the P2 position is consistent with the classification of both 
F  hepatica  proteinases as cathepsins L (Barrett and Kirschke, 1981) or
i
cathepsins S'(Bromme e t a l , 1989, Bromme e t a l , 1993) Both enzymes, 
however, have a three-fold greater affinity for the substrate Boc-val-leu-lys- 
NHMec over the substrate Z-phe-arg-NHMec, the cathepsin L2 has over 
twice the affinity for these two substrates when compared to the cathepsin 
L1 1
We analysed the activity of both cathepsin Ls on a range of fluorogemc 
peptide substrates in an effort to find substrates that could differentiate
i
i
between the two enzymes We arrived at five substrates, namely Bz-phe-val- 
arg-NHMec, H-leu-val-tyr-NHMec, Boc-val-pro-arg-NHMec, Tos-gly-pro-arg- 
NHMec and Tos-gly-pro-lys-NHMec, that are cleaved by the F  hepatica  
cathepsin L2jwith much greater affinities (38 6 - 113 3 mM' 1 s '1) than by the
cathepsin L1 j(0 3 - 3 9 mM’ 1 s '1) For this reason one of these substrates,
!
Tos-gly-pro-arg-NHMec, was chosen in this study to monitor the purification 
of the cathepsin L2 (c f Results part 3 1)
Bromme e t al (1989) showed that bovine cathepsin L had a ten-fold
4.1 KINETIC STUDIES OF CATHEPSINS L1 AND L2.
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preference for the substrate Z-phe-arg-NHMec over the substrate Z-phe-val-
I
arg-NHMec whereas bovine cathepsin S had a five-fold preference for Z-
I
phe-val-arg-NHMec over Z-phe-arg-NHMec The F  hepatica  cathepsin L1 
and cathepsin L2 have a preference for the substrate Z-phe-arg-NHMec over 
the substrate Z-phe-val-arg-NHMec (25 fold and three-fold, respectively)
i
suggesting that both enzymes are cathepsin L-like rather than cathepsin S- 
like proteinases
Il
4.2 ACTIVE SITE TITRATION OF CATHEPSINS L1 AND L2
I
Active site titration of cathepsins L1 and L2 using the cysteine proteinase
!
inhibitor E-6^ (Barrett e t a l , 1982) were performed There is approximately 10 
|iM active cathepsin L1 and approximately 1 0 ^M active cathepsin L2 
following purification which is 80% of the cathepsin L1 and 40% the
cathepsin L2 molecules present based on calculated molarities
ii
l
4.3 DIRECT FLUOROGENIC SUBSTRATE PAGE ANALYSIS
i
The substrate specificity of the F hepatica  cathepsin L1 and cathepsin L2 
were also compared by electrophoretically separating the proteins in F
hepa tica  culture medium by native polyacrylamide gel electrophoresis and
I
then immersing replicate gels in different fluorogemc substrates In native 
gels the cathiepsin L1 migrates as multiple bands whilst the cathepsin L2
i
focuses as a single slower migrating band (Smith e t a l , 1993a) (Figure 4 1)
Bands representing both enzymes are visualised with the substrates Z-phe-
!
arg-NHMec and Boc-val-leu-lys-NHMec, although the sensitivity by which 
the bands are detected is greater with the latter substrate, an observation 
that is consistent with the results of our kinetic data Also consistent with our
I
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kinetic data was the preferential detection of the cathepsin L2 within these 
gels when the substrates Tos-gly-pro-lys-NHMec and Tos-gly-pro-arg- 
NHMec are used (Figure 4 1)
4.4 NITRATION OF CATHEPSIN LS WITH TETRANITROMETHANE 
(TNM ).
TNM completely inactivates punfied F hepatica  cathepsin L2 at 
concentrations greater than 4 mM When purified cathepsin L2 was 
incubated with various concentrations of TNM, ranging from 0 5 mM to 4 mM, 
the intensity of the cathepsin L2 band in zymograms gradually decreased 
(Figure 4 2A) However, corresponding with the decrease in the intensity of 
this band was the appearance of several faster migrating bands, these 
bands became inactivated at TNM concentrations of 4 mM (Figure 4 2A) 
When the total culture medium in which adult flukes were incubated was 
treated with various concentrations of TNM we again observed the 
disappearance of the cathepsin L2 band and the corresponding appearance 
of the faster migrating bands (Figure 4 2B) In contrast, the bands 
representing cathepsin L1 were not affected by TNM even at concentrations 
of 4 mM (Figure 4 2B) The concentration of ethanol (10% v/v) used to 
dissolve the TNM did not inactivate cathepsin L1 or cathepsin L2 (Figures 
4 2A and 4 2B, lanes 2)
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Table 4.1
R eaction  kinetics for the F  hepatica ca th ep sm s L 1 a n d  L2 on pep tide  
substra tes
CATHEPSIN Ll CATHEPSIN L2
Substrate % ^caC ^cat^m kM ^cat ^ c a t^ m
(JIM) ( s ' 1 ) (UM) (s ’ 1 )
z-arg-NHMec 20 4 0 04 2 2 14 1 0.09 6 4
z-arg-arg-NHMec 65 6 0 002 0 03 9 1 0 02 2.2
z-phe-arg-NHMec 14 7 1 08 73.6 4 0 0 56 140 0
Bz-phe-val-arg-NHMec 9 3 0 03 3 0 1 2 0.06 45.8
H-leu-val-tyr-NHMec 5.4 0 02 3 9 3 8 0 21 55 5
S-leu-leu-val-tyr-NHMec 38 5 0 01 0.3 23 3 0 08 3 3
Boc-val-pro-arg-NHMec 43 6 0 02 0 5 24 8 1.19 48 0
Tos-gly-pro-arg-NHMec 26 0 0 03 1.2 17 1 1 93 113 .3
Tos-gly-pro-lys-NHMec 106 9 0 03 0 3 35 5 1.37 38.6
Suc-ala-phe-lys-NHMec 65 3 0 05 0.8 41 2 0 14 3 4
Boc-val-leu-lys-NHMec 34.7 7 90 227 7 7 3 3 75 510.9
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Figure 4.1
Direct visualisation o f ca thepsm  L1 a n d  ca thepsm  L2 pro tem a ses  in 
polyacrylam ide gels.
Aliquots of culture medium in which mature F. hepatica  were maintained (20 
ng) were applied to several lanes of a gelatin-containing 12% 
polyacrylamide gel (without SDS). Following electrophoresis the gel was 
divided into 1cm strips that corresponded to the lanes and the strips washed 
in 0 1 M glycine, pH 7 0. One strip was processed as for the zymograms 
Other strips were incubated in 10 jxM of fluorogemc peptide substrate The 
substrates used were, Z-phe-arg-NHMec (FR); Boc-val-leu-lys-NHMec (VLK), 
Tos-gly-pro-arg-NHMec (GPR) and Tos-gly-pro-lys-NHMec (GPK) After 10 
mins the gel strips were removed, transilluminated and photographed.
6 8
Nitration o f ca thepsm  L2 pro teinase with tetram trom ethane (TNM)
A  Purified cathepsin L2 (1 jig) incubated for 1 hr in vanous concentrations 
of TNM in PBS, pH 7 3. Following this incubation the mixtures were analysed 
by zymography. Enzyme preparations were incubated with PBS (control, 
lane 1), 10% ethanol (control, lane 2), 0 5 mM TNM (lane 3), 1.0 mM TNM 
(lane 4), 2 0 mM TNM (lane 5), and 4 0 mM TNM (lane 6) CL2, cathepsin L2
Figure 4.2
B  Medium in which mature F. hepatica  were maintained (20 ng) incubated 
for 1 hr in various concentrations of TNM in PBS, pH 7 3 Following this 
incubation the mixtures were analysed by zymography Enzyme preparations 
were incubated with PBS (control, lane 1), 10% ethanol (control, lane 2), 0 5 
mM TNM (lane 3), 1 0 mM TNM (lane 4), 2 0 mM TNM (lane 5), and 4 0 mM 
TNM (lane 6) CL2, cathepsin L2, CL1, cathepsin L1
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CHAPTER 5 
RESULTS PART 3 
Fibrin clot formation by Fasciola hepatica cathepsin L2: 
comparison with the clot produced by bovine thrombin
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5.1 FIBRIN CLOT FORMATION BY CATHEPSIN L2
In a previous section of this Thesis (Results part 3 1) it was shown that 
Fasciola hepatica  cathepsin L2 cleaved the protein substrate gelatin 
Fibrinogen was included in a range of macromolecules that we examined for 
susceptibility to digestion by this enzyme We noticed, however, that when 
the cathepsin L2 was added to a fibrinogen solution a rigid clot formed This 
observation prompted us to examine more closely the characteristics of this 
clotting property of the enzyme and to compare it to that of blood clotting 
agent thrombin (Factor lla) Since cathepsin L2 is a cysteine proteinase all 
reactions were carried out in the presence of the reducing agent
dithiothreitol When 2 3 x10' 3 units of cathepsin L2 was added to 100 (il of a 
20 mg ml' 1 fibrinogen solution, clots were observed within 25 min at 37°C
Clots formed within 20 min when 5 7 x 10' 3 NIH units of thrombin were
added to fibrinogen solutions (Table 5 1) Therefore the clotting ability of the 
cathepsin L2 enzyme is equivalent to 2 85 NIH units/ unit of Tos-gly-pro-arg- 
NHMec cleaving activity
Fibrinogen-agarose gels, set on microscope slides, were used to visualise 
the clot formation and to quantitate the clotting efficiency of the cathepsin L2 
using thrombin as a standard Clots formed around the wells to which the 
enzymes were added and appeared as ‘hazy’ rings The diameter of which 
can be measured and compared to the standard (Figure 5 1 A) Using this
assay it was determined that 2 3 x10' 3 units of cathepsin L (measured using 
the fluorogemc substrate Tos-gly-pro-arg-NHMec) had the equivalent clotting 
efficiency as 1 9 x10‘4 NIH units of thrombin
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Inhibitors were added with cathepsin L2 or thrombin to the wells to 
demonstrate that the clots formed were indeed a result of enzyme activity 
Hirudin, an inhibitor of thrombin, prevented the formation of clotting zones by 
thrombin but did not affect the cathepsin L2 clotting activity In contrast, the 
cathepsin L inhibitor, Z-phe-ala-CHN2 , inhibited the clotting activity of the 
cathepsin L2 but not of thrombin (Figure 5 1B)
Two observations indicate that the clots produced by thrombin and 
cathepsin L2 differ physically Firstly, the hazy zone produced on the 
fibnnogen-agarose plates by cathepsin L2 appears more ring-like than that 
produced by thrombin (Figure 5 1A) Secondly, the cathepsin L2 clot is less 
stable We observed that on vigorous vortexing, the matnx of the cathepsin 
L2 clot appeared to collapse and form a precipitate in the tube, thrombin 
clots treated in the same manner remained gel-like
5.2 ELECTROPHORETIC ANALYSIS OF FIBRIN CLOTS
Fibrin clots formed by cathepsin L and thrombin were solubilised in SDS- 
PAGE reducing sample buffer and analysed by SDS-PAGE Under reducing
conditions fibrinogen migrates as three bands that represent the a (66 kDa),
(} (52 kDa) and y (46 2 kDa) subunits (Figure 5 2A, lane 1) These three 
polypeptides were also observed when the thrombin clots were analysed 
under similar conditions, however, the a and 3 polypeptides migrated slightly 
faster due to the cleavage of the fibrinopeptides (16 and 14 amino acids, 
respectively) from these polypeptides by thrombin The y polypeptide is not 
cleaved by thrombin (Figure 5 2A, lane 3) The pattern observed for the 
cathepsin L2 produced clot is remarkably dissimilar to that of the thrombin
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clot, the a and (3 polypeptides are not observed and the y polypeptide 
migrates slightly faster However, several polypeptides of higher molecular 
size are observed two of which, of 120 kDa and 100 kDa, are the most 
predominant A faster migrating polypeptide of 25 kDa is also visualised on 
these gels (Figure 5 2A, lane 2)
To demonstrate that the polypeptides observed in the cathepsin L2 
produced clots were derived from fibrinogen, the clots were separated by 
reducing SDS-PAGE, transferred to a nitrocellulose filters an subsequently 
probed with anti-human fibrinogen antibodies This antiserum contained 
antibodies reactive with the a, (3 and y polypeptides of fibrinogen as seen 
when thrombin clots are probed (Figure 5 2B, lane 2) The antiserum also 
contained antibodies reactive with the 120, 100 and 25 kDa polypeptides 
observed in the cathepsin L2 produced clots (Figure 5 2B, lane 1) Normal 
human serum did not contain antibodies reactive with any of the above 
polypeptides (Figure 5 2B, Lane 3 and 4)
5.3 POSITIONING OF THE CLEAVAGE SITES OF THROMBIN AND 
CATHEPSIN L2 ON FIBRINOGEN
We have previously shown that F  hepatica  cathepsin L2 can cleave some 
peptide bonds that are also cleaved by thrombin, for example both enzymes 
have a high affinity for Tos*gly-pro-arg-NHMec (Results parts 4 1 and 4 2, 
Lotterberg e t a l , 1981) We used three synthetic peptides to examine 
whether the cleavage site on fibrinogen for both enzymes were the same 
The peptide H-gly-pro-arg-pro-OH corresponds to the terminal sequence of
the a-chain after removal of the fibrinopeptide A, and prevents the
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polymerisation of the fibrin monomers H-gly-pro-arg-OH is a derivative of 
this above peptide but does not prevent polymerisation The peptide H-gly-
his-arg-pro-OH corresponds to the terminal sequence of the p-chain after
removal of the fibrinopeptide B but is not an inhibitor of fibrin polymerisation 
(Doolittle, 1981)
Using the fluorogemc peptide Tos-gly-pro-arg-NHMec as a substrate for 
cathepsin L2 we demonstrated that the peptides H-gly-pro-arg-pro-OH and 
H-gly-pro-arg-OH are competitive inhibitors of cathepsin L2 (Table 5 2) At a 
20-fold molar concentration of these peptides (300 |iM) over substrate a 
>50% inhibition of cathepsin L activity was observed, however, a five-fold 
excess of peptide (75 |iM) resulted in less than 10% inhibition H-gly-his-arg- 
pro-AMC had no affect on cathepsin L2 activity None of the three fibrin- 
antipolymerants significantly inhibited thrombin activity, even at a 40 fold 
excess over substrate (Table 5 2)
The effect of these peptides, at a concentration that do not inhibit enzyme 
activity (75 jxM), on the clotting time of thrombin and cathepsin L2 was 
examined The clotting time for thrombin in the presence of H-gly-pro-arg- 
pro-OH was >9 hr compared to 20 min in the absence of the anti-polymerant 
(Table 5 1) Neither H-gly-pro-arg-OH or H-gly-his-arg-pro-OH significantly 
affected the clotting time of thrombin In contrast, the clotting time for 
cathepsin L2 was not affected by any of the three peptides (Table 5 1)
Hirudin inhibited the activity of thrombin on the substrate Tos-gly-pro-arg- 
NHMec and its ability to polymerise fibrinogen, but had no effect on 
cathepsin L2 activity Z-phe-ala-CHN2 inhibited cathepsin L2 activity on the 
fluorogemc substrate and fibrinogen but showed no effect on thrombin 
(Tables 5 1 and 5 2)
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The above data suggested that the cathepsm L cleavage site on 
fibrinogen does indeed differ to that of thrombin We examined if the 
fibrinogen cleavage site of the cathepsin L2 remained following the removal 
of fibrinopeptides A and B by thrombin Thrombin was incubated with a
fibrinogen solution (100 (il, 20 mg ml’ 1) for 100 min in the presence of the
various concentrations of the anti-polymerant H-gly-pro-arg-pro-OH This 
incubation period would allow the removal of the fibrinopeptides but would 
not allow the formation of fibrin polymers Cathepsin L2 was then added and 
to the tubes and the mixture examined for clot formation Thrombin was 
added to a second series of tubes The addition of cathepsin L2 resulted in 
the formation of clot within 10 -20 min in tubes preincubated with thrombin 
and 200 - 300 |iM anti-polymerant Tubes containing 350 and 400 |o.M 
antipolymerant formed incomplete clots (semi-clots) within 60 min , however, 
at these concentrations of anti-polymerant it was expected that some 
inhibition of the cathepsin L2 would occur (Table 5 3; see also Table 5 2) 
Whilst the addition of more thrombin to tubes preincubated with thrombin and 
anti-polymerant also produced clots, these were much slower to form (Table 
5 3)
At the end of the above experiment reducing SDS sample buffer was 
added to the tubes, the mixture boiled and the analysed by reducing SDS- 
PAGE Samples from tubes that were pre-incubated with thrombin and anti- 
polymerant (200, 300 and 400 jxM) and then additional thrombin added 
showed similar electrophoretic pattern to tubes containing no anti- 
polymerant (Figure 5 3), when compared to the untreated fibrinogen it can be 
seen that the fibrinopeptides have been cleaved by thrombin In contrast, the 
electrophoretic profile of samples from tubes in which cathepsin L2 was
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added following pre-incubation with thrombin and anti-polymerant was 
similar to the profile obtained for clots produced by cathepsin L2 alone
(Figure 5 3, see also Figure 5 2) The fibrinogen a  and (3-chams disappear, 
although in these experiments it can be seen that the digests did not go to 
completion most likely because of the inhibitory affects of the anti-
polymerant The fibrinogen y-chain migrates slightly faster, as the
concentration of the anti-polymerant in the mixtures decreases the more 
digestion of this polypeptide is observed and concurrent with this is an 
increase of the 25 kDa band
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Fibrin-clotting tim es for thrombin an d  F  hepatica ca th ep sm  L2
Table 5.1.
CLOTTING TIME ( m m  ) * 
PEPTIDE ______________________________
J thrombin cathepsm L2
control 20 25
Hirudin 1 unit
<—1 1r—I£ >540 25
Z-phe-ala-CHN2 75 |IM 30 >540
H-gly-pro-arg-pro-OH 75 um >540 40
H-gly-pro-arg-OH 75 (IM 35 35
H-gly-his-arg-pro-OH 75 [IM 30 30
* Thrombin (5 7 x10' 3 NIH units ) and cathepsm L2 (2 3 x10' 3 units) were
added to 100fil fibnnogen (20 mg m l'1) as described in Materials and
Methods The assay mixture was incubated at 37°C and the time taken to 
form a solid clot recorded
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thrombin
A Titrat ion assay
cathepsin L2 
B Inh ib ition  assay
hirudin 
Z -P-A- CHN*
TR CL
Figure 5.1
Fibrinogen-agarose plate a s sa y  o f clots produced  b y  ca thepsin  L2 and  
thrombin.
A  Titration of thrombin (NIH units x 10'3, from left to right, 5 7, 2 97,1 4, 0.7,
0 36 and 0 0) and cathepsin L2 (units x 10"3, from left to right, 2 3, 2 0,1 85,
1 4 0 9, and 0 45)
B  Inhibition assay of cathepsin L2 (2 3 x10*3 units) and thrombin (5 7 x10' 3 
NIH units) by the thrombin-specific inhibitor hirudin (3 units) and the
cathepsin L specific inhibitor Z-phe-ala-CHN2 (Z-F-A-CHN2 600p.M)
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Electrophoretic analysis o f fibrin clots
A  SDS-PAGE of fibrinogen and fibnn clots produced by thrombin and 
cathepsin L2 2 nl of bovine fibrinogen (20 mg m l'1) without added enzyme 
(lane 1), 4 jxl of the reaction mixture of bovine fibrinogen (100 |il, 20 mg ml"1) 
incubated in the presence of purified cathepsin L2 (2 3 x 10' 3 limits) (lane 2) 
and 4 \i\ of the reaction mixture of bovine fibrinogen (100 {al, 20 mg ml"1) 
incubated in the presence of thrombin (5 7 x 10' 3 units) (lane 3)
B  Immunoblotting analysis of fibrinogen clots 1 p.l of the reaction mixture of 
bovine fibrinogen (100 |il, 20 mg ml"1) incubated in the presence of 
cathepsin L2 (2 3 x10"3 units) and probed with anti- fibrinogen antibodies 
(lane 1), 1 (il of the reaction mixture of bovine fibrinogen (100 |xl, 20 mg ml"1) 
incubated in the presence of thrombin (5 7 x10"3 NIH units) and probed with 
anti-fibrinogen antibodies (lane 2), 1 nl of the reaction mixture of bovine 
fibrinogen (100 jxl, 20 mg ml"1) incubated in the presence of cathepsin L2 
(2 3x10"3 units) and probed with normal human serum (lane 3), and 1 jxl of 
the reaction mixture of bovine fibrinogen (100 jj.I, 20 mg m l'1) incubated in 
the presence of thrombin (5 7 x10"3 units) and probed with normal human
serum (lane 4) The molecular weight markers were p-galactosidase (125 
kDa), Fructose-6-phosphate kinase (88 kDa), pyruvate kinase (65 kDa), egg 
albumin (45 kDa),glyceraldehyde-3-phosphate dehydrogenase (36 kDa), 
carbonic anhydrase (29 kDa), trypsinogen (24 kDa), soybean trypsin 
inhibitor (20.1 kDa) and a-lactalbumin (14 2 kDa)
Figure 5.2
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A. B.
- i
The ef fect  o f  anti-polym erants on the Tos-gty-pro-arg-NHM ec cleaving  
ability o f  thrombin (5 7 x  10~3 NIH units) an d  F  hepatica ca thepsm  L2 (0 5  x
10 '3 units)
Table 5.2.
Inhibition*
(% activity remaining) 
PEPTIDE ____________________________
thrombin cathepsm L2
control 100 100
Hirudin 1 unit ml--*- 8 97
Z-phe-ala-CHN2
75 (IM 96 12
300 JIM 72 6
H-gly-pro-arg-pro-OH
75 flM 98 96
300 pi 80 42
H-gly-pro-arg-OH
75 (1M 96 93
300 |1M 82 43
H-gly-his-arg-pro-OH
75 |IM 110 102
300 pM 98 99
* data represents mean of results from three separate assays
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Table 5.3.
Fibrin-clotting tim es for thrombin and  cathepsm  L2 following a pre- 
m cubation o f  fibrinogen with thrombin and  anti-polym erant
Time
0 200
H-gly-
250
-pro-arg-pro-OH (|i.M) * 
300 350 400
0 ' + thrombin* + - - -
+ cathep.L + - - -
10 ' + thrombin + - - _  -
+ cathep L + + /- - -
20 ' + thrombin + + - -  -
+ cathep. L + + + + -
30 ' + thrombin + + - -  —  —
+ cathep L + + + + -
60' + thrombin + + + + / -
+ cathep L + + + + + / -  + / -
Fibrinogen (100 \i\, 20 mg m l'1) was pre-incubated with thrombin (5 7 x10' 3 
NIHumts) in the presence various concentrations of the anti-polymerant H- 
gly-pro-arg-pro-OH for 100 min at 37°C Thrombin (5 7 x10"3 NIH units) or
cathepsin L2 (2 3 x10' 3 units) was then added and the time taken for clot 
formation recorded Arbitrary scales are, no clot -, semi-clot +/- and clot +
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thrombtn cathep L2
Figure 5.3
Electrophoretic analysis o f fibrin clots form ed su b se q u e n t to pre-incubation  
o f fibrinogen with thrombin a n d  fibrin anti-polym erants
Fibr, 2 i^l of Fibrinogen (20 mg ml"**) without added enzyme , thrombin 200, 
300 and 400; 4 jj.1 of the reaction mixture of fibrinogen (100 nl, 20 mg m l'1) 
pre-incubated with 200 |iM, 300 |j.M and 400 nM of anti-polymerant and 5 7 
x10' 3 NIH units of thrombin with subsequent application of 5 7 x10' 3 NIH 
units of thrombin. T r , 4 jil of the reaction mixture of fibrinogen (100 jil, 20 mg 
ml"1) incubated with 5 7 x 10' 3 NIH units of thrombin Cath L2 200,300 and 
400; 4 jul of the reaction mixture of fibrinogen (100 (il, 20 mg m l'1) pre- 
incubated with 200 nM, 300 nM and 400 (xM of anti-polymerant and 5 7 x 1 0 '  
3 NIH units of thrombin and subsequent application of 2 3x10*3 units of 
cathepsin L2. The molecular weight markers were as follows. |3- 
galactosidase (125 kDa), Fructose-6-phosphate kinase (88 kDa), pyruvate 
kinase (65 kDa), egg albumin (45 kDa), glyceraldehyde-3-phosphate 
dehydrogenase (36 kDa), carbonic anhydrase (29 kDa), trypsinogen (24 
kDa), soybean trypsin inhibitor (20 1 kDa) and a-lactalbumin (14 2 kDa)
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CHAPTER 6 
D ISC U SSIO N
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C haracterisation o f a se c o n d  Fasciola hepatica ca thepsm  L
The first trematode cathepsin L to be characterised was isolated by 
Smith e t a l  (1993a) from medium in which the mammalian parasite, 
Fasciola hepatica  , was cultured The proteinase was classified as a 
cathepsin L because of its location in vesicles, N-terminal sequence of its 
first 20 ammo acids and its preference for cleaving fluorogemc peptide 
substrates with hydrophobic amino acids in the P2 position (Schecter and 
Berger nomenclature, Schecter and Berger, 1967) Dalton and Heffernan 
(1989), however, had shown that multiple cysteine proteinases were 
secreted into culture medium by the parasite They speculated that the 
parasite used these proteinases for feeding and migration as they were 
shown to be present in immature and adult parasites Eleven bands of 
proteolytic activity were observed by Dalton and Heffernan (1989) all of 
which were subsequently shown to be enhanced by reducing reagents and 
inhibited by cysteine proteinase specific inhibitors This thesis describes the 
isolation, to homogeneity, of a second cysteine proteinase secreted into 
culture medium by adult F hepatica  parasites N-terminal sequence data 
and experiments on the substrate specificity of the enzyme reveal that this 
cysteine proteinase is also a cathepsin L. For the purpose of clarity, the 
cathepsin L isolated by Smith e t a l  (1993a) is referred to as cathepsin L1 
and the proteinase described in this thesis designated cathepsin L2 
Cathepsin L2 proteinase has the unique property among parasitic 
proteinases of cleaving fibrinogen in such a manner as to form a fibrin clot 
which is different to the type of fibrin clot produced by the serum proteinase 
thrombin (factor lla) This novel property of cathepsin L2 is described in this
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thesis also
Purification o f a se c o n d  cyste ine  proteinase from adult Fasciola hepatica  
culture m edium
A two-step purification protocol was designed to a) separate the 
cysteine proteinase fraction from other proteins and peptides present in adult 
F  hepatica  culture medium by using gel-filtration chromatography and b) 
separate the two cysteine proteinases, present in the cysteine proteinase 
pool from the initial gel-filtration step, from each other by using amon- 
exchange chromatography The presence of the second cysteine proteinase 
which has a substrate specificity distinct to the F  hepatica  cysteine 
proteinase described by Smith e t a l  (1993a) was specifically measured 
using the fluorogemc peptide substrate Tos-gly-pro-arg-NHMec (see below) 
Both the gel-filtration and ion-exchange columns were equilibrated in 0 1 M 
Tris buffer, pH 7 Therefore, gel-filtration as the first step of the punfication 
procedure was designed to achieve both separation of the proteins present 
in F  hepatica  culture medium according to molecular weight, and 
equilibration of the separated proteins into the buffer used for the 
subsequent amon-exchange-chromatography step This makes the 
purification procedure simpler and more rapid by avoiding extra 
concentration and buffer exchange steps which may also adversely affect 
proteinase activity
A single peak of cysteine proteinase activity, was observed following 
gel-filtration chromatography of the F  hepatica  culture medium The 
cysteine proteinase specifically measured using the substrate Tos-gly-pro-
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arg-NHMec, has a molecular weight of approximately 30 kDa according to 
the results of its migration on the gel-filtration column The results of protein 
estimation from the BCA assay show that 5% of the protein applied to the 
gel-filtration column is recovered in the peak containing the cysteine 
proteinase activity When protein content is estimated by the U V 
absorbance profile of the material eluted from the gel-filtration column, it is 
evident that a higher proportion (approximately 25%) of the total protein 
applied to the column is recovered This shows that the BCA assay gives 
lower readings for the amount of protein present during purification than 
protein measurement by U V absorbance
Anion-exchange chromatography using QAE-Sephadex resin 
followed gel-filtration in the purification procedure QAE-Sephadex binds 
proteins with a net negative charge at pH 7 The pool of cysteine proteinase 
activity from the gel-fiItration stage was applied directly to the QAE- 
Sephadex column The cysteine proteinase described by Smith e t  al 
(1993a) does not bind to QAE-Sephadex at pH 7 and is therefore eluted in 
the flow-through fraction The QAE-Sephadex column was subsequently 
washed with 5 column volumes of 0 1M Tris pH 7 to remove any traces of the 
proteinase described by Smith e t al (1994a)
The cysteine proteinase descnbed in this thesis binds to QAE- 
Sephadex at pH 7 Before elution with 400 mM NaCI, the QAE-Sephadex 
column was washed with 75 mM NaCI A small amount of protein which did 
not contain cysteine proteinase activity was eluted with 75 mM NaCI 
Cysteine proteinase was subsequently eluted from the QAE-Sephadex resin 
with 400 mM NaCI As the cysteine proteinase was only eluted by the higher 
salt concentration it is evident that it binds firmly to QAE-Sephadex resin at
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pH 7 Therefore QAE-Sephadex chromatography at pH 7 distinguishes 
between two cysteine proteinases present in F  hepatica  culture medium and 
is a good method to separate both of these enzymes from each other
The two column purification procedure descnbed in this thesis results 
in a 149-fold of cysteine proteinase with approximately 30% recovery of 
active enzyme A two step purification procedure using similar 
chromatographic procedures to those described above was used by Smith 
e t  a! (1993a) to purify the cysteine proteinase with cathepsin L-like 
properties from medium in which adult F hepatica  were incubated Smith 
etal .  (1993a) achieved a recovery of 12% active enzyme following 
purification which is lower than the recovery achieved for the cysteine 
proteinase described in this work This difference in fold-punfications could 
be due to the possible lower abundance of the present cysteine proteinase 
in the culture medium compared to the cysteine proteinase descnbed by 
Smith e t  a l , (1993a) Alternatively the proteinase described by Smith e t  a l , 
(1993a) may be less stable during purification than the cysteine proteinase 
described in this work.
Reducing SDS-PAGE of the pool from the QAE-Sephadex 
chromatography shows a single band of protein at 29 5 kDa Reducing 
SDS-PAGE results of total adult F  hepatica  culture medium, shows a second 
major protein present which has a molecular weight of 27 kDa The results 
of the purification of a previously described cysteine proteinase from adult F 
hepa tica  culture medium show that the 27 kDa protein band corresponds to 
the enzyme isolated by Smith e t a l  (1993a)
Zymograms containing SDS show that the lower proteolytic bands 
present in F hepatica  culture medium can be separated from the upper
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proteolytic bands The upper proteolytic bands are due to the single 
cysteine proteinase of 27 kDa described by Smith e t a l  (1993a)
Zymography without SDS show that these ‘lower bands’ are due to a single 
proteinase Therefore, both zymography and reducing SDS-PAGE revealed 
that the two-step purification procedure used in this work separates the two 
cysteine proteinases and results in an homogeneous preparation of a 
second F hepatica  cysteine proteinase
The procedure used in this thesis to purify the second F hepatica  
cysteine proteinase is different to the procedures utilised by other 
investigators to purify F hepatica  cysteine proteinases Rege e t a l  (1989), 
purified a cathepsin L-like enzyme of 14 5 kDa from homogenates of F 
hepatica  using MonoS cation-exchange chromatography and molecular 
sieve HPLC Both columns were prepared at pH 5 0 Unlike this study and 
that of Smith e t a l  (1993a), Rege e t a l ,  (1989) did not find more than one 
form of cysteine proteinase enzyme
Yamasaki e t a l  (1989) did not use ion-exchange chromatography to 
purify a cysteine proteinase enzyme They achieved substantial purification 
using gel-filtration and affinity chromatography using activated thiol- 
Sepharose Activated thiol-Sepharose selects for proteins with exposed 
cysteine residues (DeMartino, 1989) As both cysteine proteinases isolated 
from adult F hepatica  culture medium have cysteine active site residues, the 
procedure of Yamasaki e t a l  (1989) would not have separated the cysteine 
proteinases Therefore their purified preparation may have contained both 
cysteine proteinases
Wijffels e t al. (1994) purified cysteine proteinases from media in 
which adult F  hepatica  were incubated using a single size exclusion
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chromatography step They pooled fractions containing a 26 kDa species 
(as assessed by the results of non-reducing SDS-PAGE) for further analyses 
This protein was subsequently analysed by Western blot and reducing SDS- 
PAGE and was found to have heterogeneity Reducing SDS-PAGE of the 
pooled fraction showed a major protein band of 28 kDa with less intensely 
staining bands migrating at lower molecular weights It was also found by 
using 2-dimensional PAGE that the cysteine proteinase resolved into 3 
major peaks of diffenng pis This indicates that Wijffels e t  a l (1994) also 
observed more than one type of F  hepatica  cysteine proteinase but they did 
not attempt further punfication of these proteins
The above investigators purified cysteine proteinases from adult F  
hepa tica  homogenates (Yamasaki e t a l , 1989, Rege e t a l , 1989) or F  
h epa tica  culture medium (Wijffels e t al ,1994) None of these studies 
resulted in the isolation of more than a single cysteine proteinase although it 
is evident that more than a single cysteine proteinase is present in F  
hepatica  (Heussler and Dobbelaere, 1994) The results in this thesis 
describe the separation for the first time of two cysteine proteinases from 
adult F. hepatica  culture medium by column chromatographic methods As 
both of these enzymes were isolated to homogeneity it was therefore 
possible to compare these enzymes on the basis of their enzyme activities, 
N-terminal sequences and electrophoretic profiles
Com parison o f ca th ep sm s L1 a n d  L2
The cysteine proteinases present in F hepatica  culture medium 
can be resolved into two fractions by QAE-Sephadex chromatography The
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differences in binding of these two enzymes to QAE-Sephadex lon- 
exchange resins demonstrates that there is a major charge difference in the 
molecules at pH 7 0 From the results of reducing SDS-PAGE, the cysteine 
proteinase isolated by Smith e t a l  (1994a) (cathepsin L1) is 27 kDa and the 
cysteine proteinase isolated in this thesis (cathepsin L2) is 29 5 kDa Since 
the two molecules differ in molecular size, this charge difference may reside 
in the amino acids present in the extra 2 5 kDa of cathepsin L2 but not 
present in cathepsin L1
The data published by Smith e t a l  (1993a) and that presented here 
demonstrate that adult F hepatica  secrete two cathepsin L proteinases An 
immediate explanation for the presence of two cathepsins L in the F 
hepatica  culture medium is that cathepsin L1 (27 kDa) is a processed form 
of cathepsin L2 (29 5 kDa) or both are processed from a higher molecular 
sized parent form However, a companson of the N-terminal sequence of the 
two enzymes reveals that this is not the case The enzymes have different 
amino acid residues at position seven from the N-terminal region, which is 
the most highly conserved region in cathepsin Ls (Dufour e ta l., 1987, Mason 
e t a l , 1986) Cathepsin L2 has an arginine residue at this position whereas 
cathepsin L1 has a proline residue
From the results of the sequences of the first 14 amino acids of 
cathepsin L1 (Smith e t a l , 1993a) and cathepsin L2 both enzymes are highly 
similar (47%) to mammalian and avian cathepsins L enzymes (Ishidoh e t a t ,  
1987b, Mason e t a l , 1986, Turk e t a l , 1985, Dufour e t a l  , 1987) In contrast, 
cathepsins L1 and L2 are not so similar to cathepsin B from the closely 
related trematode parasite Sch isto som a  m a n so m  (20%) (Feilleisen and 
Klinkert, 1990) The two cathepsins L from F hepatica  show more identity to
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a cathepsm L-like enzyme (cruzain or cruzipain) (Cazzulo e t a l , 1989) from 
the protozoan parasite Trypanosoma cruzi (40%) than to the S m anson i 
cathepsm B Interestingly, cathepsm L1 and L2 are more similar to 
mammalian cathepsins L than they are to the parasite cathepsm L-like 
enzyme (47% vs 40% respectively) The cathepsins L1 and L2 sequences 
are equally similar to mammalian cathepsm S (Wiederanders e t a l , 1991) 
and mammalian cathepsins L (47%) However, enzyme kinetic studies show 
that both F  hepatica  cysteine proteinases are cathepsm L-like and not 
cathepsm S-like (see below)
Further evidence to demonstrate that cathepsm L1 was not a 
processed form of cathepsm L2 was obtained by immunoblotting 
expenments Adult F hepatica  extract homogenised with or without 
proteinase inhibitors, medium in which adult F hepatica  were incubated, 
purified cathepsm L1 and purified cathepsm L2 were separated by reducing 
SDS-PAGE, transferred to nitrocellulose membranes and probed with 
antiserum which recognised both cathepsm L1 and L2. The enzymes 
present in adult worm extract are of the same molecular size (29  5 kDa and 
27 kDa) as the proteinases secreted into the culture medium and the purified 
cathepsins L1 and L2 The results of the immunoblotting expenments were 
the same both in the presence and absence of proteinase inhibitors No 
pro- form of cathepsm L1 or L2 was detected in the adult worm extracts either 
in the presence or absence of proteinase inhibitors This indicates that the 
pro-form of cathepsm L1 and L2 is converted to the mature enzyme very 
rapidly Furthermore, if cathepsm L1 was the mature processed form of 
cathepsm L2 then it would be expected that cathepsm L1 alone would be 
detected in the F  hepatica  culture medium Mammalian cathepsm L is
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synthesised as an inactive pro- form of 39 kDa and this molecule is 
subsequently processed by proteolysis to the mature form of 30 kDa 
(Nishimura e t a l , 1988, Hara e t a l , 1988, Rowan e t a l , 1992) The 
difference in molecular weight between the pro- and mature form of 
mammalian cathepsin L is 9 kDa which is considerably larger than the 2 5 
kDa difference between F hepatica  cathepsin L1 and L2 which further 
supports the evidence that cathepsin L1 is not the processed form of 
cathepsin L2
Zymography in the presence of SDS was one method used to detect 
and compare proteolytic activities of cathepsins L1 and L2 Gelatin was co- 
polymerised into an SDS-PAGE gel as the protein substrate for zymography 
Following separation of the proteins by SDS-PAGE, the gel was washed and 
then incubated for a sufficient length of time to allow digestion of the gelatin 
in the gel by the proteinase enzymes Following the incubation step, the 
gelatin in the PAGE gel was stained with coomassie blue dye Proteinase 
activity was visualised as clear bands where the gelatin was digested by the 
proteinases The samples were not denatured by boiling or reduced with 
mercaptoethanol in order that enzymatic activity was retained
When the proteinase activity in F  hepatica  culture medium was 
visualised by zymography with incorporated gelatin as the protein substrate, 
11 distinct proteinase bands are present (Dalton and Heffernan, 1989)
These proteinase bands were divided into two groups on the basis of their 
pH optima for cleavage of gelatin Group 1 with a pH optimum of 3-4 5 
contains 5 bands in the 60 to 88 kDa range and Group 2 with a pH optimum 
of 4 5 to 8 , contains 6 bands in the 27 5 to 46 kDa range Subsequent protein 
purification studies by Smith e t a l  (1993 a,b) showed that the Group 1
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proteinases are due to a single proteolytic enzyme, cathepsin L1 The 
results of this study show that the Group 2 enzymes correspond to single 
enzyme, cathepsin L2
The proteinases present in adult F hepatica  culture medium were 
also visualised by zymography without SDS This technique visualises 
proteinases following electrophoretic separation based on both size and 
charge (Dowd e t a l , 1994, Smith e t a ! , 1994) When F hepatica  culture 
medium containing both cathepsms L1 and L2 is subject to zymography 
without SDS, cathepsin L1 migrates as multiple bands while cathepsin L2 is 
visualised as a single band
Studies using the protein modifying reagent, TNM, also 
demonstrated a structural difference between the two F  hepatica  cathepsins 
L Under mild conditions, as employed in this study, TNM is highly specific for 
tyrosyl modification (Eyzaguirre, 1987) Under these conditions, nitration of 
tyrosine residues by TNM produces an tonisable chromophore, 3-Nitro- 
tyrosine (Eyzaguirre, 1987) However, under more vigorous conditions (high 
molar concentrations or reactions carried out at high pH values) other 
residues such as histidine, tryptophan and methionine are modified (Riordan 
and Vallee, 1972) These residues must not be accessible to TNM on the 
cathepsin L1 molecule since this enzyme was not inactivated by this reagent 
In contrast, nitration of cathepsin L2 modification resulted in inactivation of 
the enzyme The cathepsin L2 is 2 5 kDa larger than the cathepsin L1, the 
part of the cathepsin L2 that make up this additional 2 5 kDa may contain the 
residues that are susceptible to modification by TNM
The inactivation of cathepsin L2 by TNM was visualised by zymography 
without SDS for the reasons outlined above Following incubation with
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increasing concentrations of TNM the proteolytic band representing the 
cathepsin L2 gradually disappeared Accompanying this disappearance was 
the gradual appearance of several faster migrating bands The faster 
migrating bands may be various modified forms of the enzyme each with a 
different number of residues modified Alternatively, modification of the 
cathepsin L2 with TNM may cause the unfolding of the molecule which then 
becomes vulnerable to auto-digestion, if this were the case the faster 
migrating bands may be active fragments of the enzyme
Cathepsms L are proteinases that have a high affinity for the peptide 
substrate Z-phe-arg-NHMec and have little affinity for the substrates Z-arg- 
arg-NHMec and Bz-arg-NHMec (Barrett and Kirschke, 1981) The F 
hepa tica  cysteine proteinases studied by Smith e ta l. (1993a) and the 
cysteine proteinase studied in this thesis favour Z-phe-arg-NHMec over Z- 
arg-arg-NHMec and Z-arg-NHMec which demonstrates that both enzymes 
belong to the cathepsin L class (Barrett and Kirschke, 1981) This confirms 
the results of N-termmal amino acid sequencing which demonstrated that 
both the first 14 N-terminal ammo acids of cathepsms L1 and L2 share 
substantial homology with the first 14 N-termmal ammo acids of mammalian 
cathepsms L It is unlikely that F hepatica would secrete two proteinases of 
the same specificities especially as they both are the most abundant proteins 
secreted by the parasite according to the results of reducing SDS-PAGE 
Therefore, the possibility that cathepsin L1 and L2 differ in their substrate 
specificities was investigated using a bank of 11 commercially available 
fluorogemc substrates
The mammalian cathepsin S proteinase, shares similar properties to 
cathepsin L (Bond and Butler, 1987, Kirschke e t a l , 1986, Bromme e t a l ,
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1989) From the results of the N-termmal sequences of their first 14 amino 
acids the F hepatica  cysteine proteinases are equally homologous to 
mammalian cathepsin S and cathepsin L Therefore the possibility of the two 
F  hepatica  cysteine proteinases being cathepsins S rather than cathepsins 
L was investigated Cathepsin S and cathepsin L can be distinguished by a 
comparison of their affinities for the fluorogemc substrates Z-phe-arg-NHMec 
and Z-phe-val-arg-NHMec (Bromme e t a l , 1989) Cathepsin S has a five­
fold higher affinity for Z-phe-val-arg-NHMec than for Z-phe-arg-NHMec 
Cathepsin L has a higher affinity for Z-phe-arg-NHMec over Z-phe-val-arg- 
NHMec Both cathepsin L1 and L2 cleave Bz-phe-val-arg-NHMec with less 
affinity that they cleave Z-phe-arg-NHMec confirming that neither cathepsin 
L1 nor L2 could be classified as cathepsins S (Bromme e t a l , 1989)
Both cathepsins L1 and L2 had an approximately 3-times greater 
affinity for Boc-val-leu-lys-NHMec than for Z-phe-arg-NHMec Few cathepsin 
Ls have a higher affinity for this substrate than for Z-phe-arg-NHMec except 
for the cathepsin L-like enzyme from the trematode parasite, P arag o m m u s  
w esteram i (Yamakami and Hamajima, 1989) The relative efficiency of Boc- 
val-leu-lys-NHMec over Z-phe-arg-NHMec as a substrate for assaying 
cathepsins L1 and L2 may be explained by the presence of leucine in the P2 
position Leucine is similar to phenylalanine in being a hydrophobic amino 
acid but its R-group is aliphatic rather than aromatic Therefore the S2 
pocket of the Fasciola hepatica  cathepsins L1 and L2 active sites may 
accommodate aliphatic hydrophobic amino acids in preference to aromatic 
hydrophobic amino acids
Cathepsins L1 and L2 also have a preference for glycine over valine 
in the P3 position of peptide substrates since they cleave Tos-gly-pro-arg-
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NHMec in preference to Boc-val-pro-arg-NHMec As glycine is a non-polar 
amino acid but smaller than valine, the S3 sites of both cathepsins L1 and L2 
seem to have a preference for small non-polar amino amino acid residues 
The tetrapeptide Suc-leu-leu-val-tyr-NHMec is far less readily 
hydrolysed than the tri-peptide H-leu-val-tyr-NHMec by cathepsins L1 and 
L2 This result may indicate that tetrapeptides do not fit into the active sites of 
cathepsins L1 and L2 as readily as di- and tn-peptides
The peptide substrates Boc-val-pro-arg-NHMec, Tos-gly-pro-arg- 
NHMec and Tos-gly-pro-lys-NHMec were cleaved with much higher affinity 
(approximately 100-fold) by cathepsin L2 than by cathepsin L1 These 
substrates have a proline residue in the P2 position Proline is an imino acid 
because its side chain is bonded to the nitrogen as well as to the a-carbon of 
the central compound This restricts the geometry of the peptide in which it is 
incorporated Because the presence of a proline residue in a peptide may 
alter the structure of the peptide due to the absence of a free amino group, 
the shape of the cathepsin L2 active site may differ to the shape of the 
cathepsin L1 active site
The cleavage of peptide substrates by cathepsins L1 and L2 may 
provide clues to the types of protein substrates which may be cleaved in
vivo by these enzymes For example, the al and a 2  chains of tropocollagen
in type I collagen, the most common collagen found in tendons, bone, skin, 
ligaments, cornea and internal organs, is composed of a regularly repeating 
sequence in which glycine is found at every third residue (Rawn, 1989) This 
sequence can be written (gly-X-Y)n , where the Xs and Ys are often proline 
and hydroxyproline Cathepsin L2 therefore, may specifically recognise this
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sequence and may be more efficient at cutting type I collagen than cathepsin 
L1 Cathepsin L2 may play a more important role than cathepsin L1 in the 
migration of the parasite as it would need to be able to breakdown internal 
organs to achieve its task of migrating from the duodenum to the liver 
Studies on the cleavage of collagens by cathepsins L1 and L2 are in 
progress (Drs C Carmona and J Dalton, personal communication)
Direct visualisation of cathepsin L1 and L2 activity in zymograms 
(without SDS) was possible by incubation of gels in peptide fluorogemc 
substrates When the zymogram was developed for Z-phe-arg-NHMec and 
Boc-val-leu-lys-NHMec cleaving activities, both cathepsins L1 and L2 are 
shown to be equally active on these substrates The fluorogemc peptide 
substrate, Boc-val-leu-lys-NHMec is preferentially cleaved by both cathepsin 
L1 and L2 When the zymograms are incubated in the fluorogemc substrates 
Tos-gly-pro-arg-NHMec and Tos-gly-pro-lys-NHMec, cathepsin L2 cleaves 
both of these substrates better than cathepsin L1 Zymography in the 
presence of fluorogemc peptide substrates support the enzyme kinetics 
studies and further demonstrate the different substrate specificities of 
cathepsin L1 and L2
To summarise, having the two F  hepatica  cysteine proteinases in 
homogeneous form provided the opportunity to compare their reaction 
kinetics on a range of peptide substrates and to N-terminally sequence each 
enzyme These studies classified the two F  hepatica  cysteine proteinases 
as cathepsin L-like From the enzyme kinetics studies it is clear that the two 
cathepsin Ls have different substrate specificities and represent distinct 
subclasses of cathepsin L The two cathepsins L also differ in their 
susceptibility to modification by TNM
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Com parison o f F  hepatica ca thepsm s L to ca th ep sm s L from other parasites
Until recently it was thought that parasitic trematodes produce 
cathepsin B-like and not cathepsin L-like proteinases ( British Society of 
Parasitology Proteinase workshop, Spring meeting 1992, York, England) 
The first cathepsin L produced by a parasitic trematode was isolated from F  
hepatica  by Smith e t a l  (1993a) This study describes the isolation of a 
second F hepatica  cathepsin L Since the paper of Smith e t a l  (1993a) 
cathepsin L proteinases from other trematodes have been described
The blood fluke,Sc/7/stoso/77a m a n so m  is the causative agent of the 
major human disease Bilharzia which occurs in tropical areas This 
trematode parasite is closely related to the liver fluke, F hepatica S  
m a n so m  has been shown to possess a cysteine proteinase called Sm31 
which is classed as a cathepsin B on the basis of its hydrolysis of the 
fluorogemc substrate Z-arg-arg-NHMec (Gotz and Klinkert, 1993) and 
because the sequence of a cDNA transcript encoding Sm31 shows 
homology with cathepsin B genes ( Klinkert e ta l., 1989) Sm31 is an 
important diagnostic antigen and may function as a haemoglobinase ( Gotz 
and Klinkert, 1993, Klinkert e t a l , 1987,1989, Ruppel e t a l , 1985, Davis e t 
a l , 1987) Because F hepatica  was shown to have a cathepsin L, the 
possibility that S m a n so m  may also have a cathepsin L was investigated 
Fluorogemc substrate assays and molecular cloning studies demonstrated 
that S. m ansom  indeed express a cathepsin L enzyme (Smith e t a l , 1994) 
From the deduced ammo acid sequence of the cDNA encoding the S 
m a n so m  cathepsin L the enzyme has a molecular weight of 24 kDa The S 
m ansom  cathepsin L gene exists as a single copy (Smith e t a l , 1994) This
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is in contrast to F hepatica  which has multiple copies of its cathepsin L gene 
(Heussler and Dobbelaere, 1994) The S m ansom  cathepsin L proteinase 
was suggested to be involved in haemoglobin digestion in conjunction to the 
cathepsin B proteinase (Smith e t a l  1994)
Paragornm us w esterm am  is a medically important trematode parasite 
which causes human paragonimiasis Paragonimiasis a disease of the 
lungs which may be associated with tumour formation (Smyth, 1979) 
P aragom m us w esterm am  produces a cysteine proteinase termed neutral 
thiol proteinase (NTP) (Yamakami and Hamajima, 1989, Hamajima e t a l , 
1994) NTP is an immunosuppressive agent (Hamajima e ta l., 1994) and 
has been shown to share homologies with cathepsin L enzyme using 
molecular cloning studies (Hamajima e t a l ,  1994) NTP cleaves the 
fluorogemc substrate Boc-val-leu-lys-NHMec in preference to Z-phe-arg- 
NHMec (Yamakami and Hamajima, 1989) This substrate preference is 
similar to that described here for F hepatica  cathepsins L1 and L2 
The zoonotic hookworm, A ncylostom a cam num  is a nematode 
parasite which is mainly an infection of dogs Recently, A cam num  has 
been shown to be the causative agent of a medical condition called 
eosinophilic enteritis (EE) of humans resident in the tropical regions of 
Australia (Prociv and Croese, 1990) EE is probably caused by the induction 
of allergic responses to the secretions of A canm um  A  cam num  is known to 
secrete a metalloproteinases which has elastinolytic activity and inhibits 
fibrin clot formation (Hotez and Cerami, 1983) However, A cam num  also 
secretes a cysteine proteinase that cleaves Z-phe-arg-NHMec in preference 
to Z-arg-arg-NHMec and Z-arg-NHMec These results indicate that A  
cam num  cysteine proteinase may have a cathepsin L-like specificity similar
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to that found for the F  hepatica cathepsins L1 and L2 The A canm um  
cathepsin L may be involved in the induction of the allergic reactions 
observed in EE (Dowd e t a l , 1994)
The African trypanosomesTrypanosom a co n g o len se  and 
Trypanosom a brucei are parasites which cause the usually fatal disease 
known as sleeping sickness These protozoan parasites infect humans and 
domestic animals such as sheep and cattle Both of these parasites produce 
cathepsin L-like enzymes (Mbawa e t a l , 1992, Mottram e t a l, 1989, 
Robertson e t a l ,1990) The cathepsin L-like proteinase produced by T  
c o n g o le n se  has a molecular weight of 31-32 kDa From cloning studies, 
the cathepsin L-like enzyme from T  brucei was found to have a molecular 
weight of 23 1 kDa The T congo lense  cathepsin L-like enzyme cleaves Z- 
phe-arg -NHMec with a Km which is similar to the Km of the F hepatica  
cathepsins L1 and L2 for Z-phe-arg-NHMec (Mbawa e t a l , 1992) T  brucei 
cathepsin L-like proteinase has a similar fluorogemc peptide substrate 
specificity as F hepatica cathepsins L1 and L2 ( Robertson e t al ,1990) T. 
co n g o len se  cathepsin L-like enzyme cleaves fibrinogen but the cleavage 
pattern is different to the cleavage pattern obtained using F hepatica  
cathepsin L (see below)
Trypanosom a c ru z i, is a protozoan parasite found in South America, 
is the causative agent of Chaga’s disease The cysteine proteinase from T. 
cruzi (called cruzipain or cruzain) has been well characterised (Cazzulo e t  
a l , 1989, 1990, Bontempi e t a l ,  1989, Murta e t al., 1990, Bontempi and 
Cazzulo, 1990, Eakin e t a l , 1992) Cruzain cleaves the fluorogemc 
substrate Z-phe-arg-NHMec with a Km similar to the Kms found for the F  
h epa tica  cathepsins L1 and L2 The N-terminal sequence (14 amino acids)
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of cruzam is 40% similar to the amino acid sequence of F hepatica  
cathepsins L1 and L2 Furthermore, cruzam degrades IgG in a similar 
manner to the F hepatica  cathepsin L1 (Smith e t a l ,  1993b, Carmona e t a l ,  
1993, Bontempi and Cazzulo, 1990)
The protozoan parasite, Theilena parva  is the tick-bourne causative 
agent of an acute and usually fatal disease in cattle T parva  produces a 
cathepsin L-like proteinase which has been cloned and sequenced (Nene 
e t a l , 1990) From the deduced ammo acid sequence of its cDNA sequence 
the7 parva  cysteine proteinase was found to have a molecular weight of 
23 5 kDa The 7 parva  cysteine proteinase exhibits a similar substrate 
preference to F hepatica  cathepsins L1 and L2 as it cleaves Z-phe-arg- 
NHMec in preference to Z-arg-arg-NHMec and Z-arg-NHMec (Nene e t a l ,
1990) The 7 parva  cathepsin L-like enzyme therefore shares a similar 
molecular weight and N-terminal sequence to F hepatica  cathepsins L1 and 
L2
Protozoan parasites belonging to the genus P lasm odium  are the 
causative agents of malaria the most important human parasitic disease P  
falciparum  and P vm ckei are both known to produce cathepsin L-like 
enzymes which may play a role in the digestion of haemoglobin (Rosenthal 
e t a l , 1988 ,1989 ,1993) The P vm ckei cysteine proteinase has a similar 
molecular weight (28 kDa) to F hepatica  cathepsins L1 and L2 and shares a 
similar substrate specificity (Rosenthal e t a l , 1993) Plasm odium  falciparum  
also possess a cathepsin L-like cysteine proteinase which has a similar 
peptide substrate hydrolysis profile to F hepatica  cathepsins L1 and L2 
(Rosenthal e t a l , 1989)
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C athepsin  L2 converts soluble fibrinogen into an  insoluble fibrin clot b y  a 
novel m echan ism
From a survey of the literature it was found that the blood clotting 
enzyme thrombin (factor lla , EC 3 4 21 5) cleaves peptide substrates with 
arginine in the P-| position and glycine in the P2 position This substrate 
specificity is similar to that demonstrated here for cathepsin L2 (Lottenberg 
e t a l , 1981) Thrombin is a serine proteinase that plays a central role in 
blood clotting by cleaving soluble fibrinogen to form a insoluble fibrin clot 
(NG e t a l , 1993, Doolittle, 1981) When cathepsin L2 is added to bovine
fibrinogen at a concentration of 20 mg ml"1 an insoluble clot forms This is
the first demonstration of the clotting of fibrinogen by a cysteine proteinase 
Apart from thrombin and cathepsin L2, only the snake venom serine 
proteinases cause fibrinogen to clot (Shieh e t a l , 1985, Pirkle e t a l , 1986, 
Fand e t a l , 1989, Dyr e t a l , 1989, Nishida e t a l , 1994)
Having demonstrated that cathepsin L2 can cause fibrin to clot its 
mechanism of clot formation was compared to that of thrombin Hirudin, a 
protein of 65/66 amino acid residues, is an extremely tight binding and 
selective inhibitor of thrombin It inhibits the activity of thrombin by mimicking 
the binding of thrombin to its natural substrate, fibrinogen i e the tail of 
hirudin binds to the fibrinogen-bmdmg exosite of thrombin (Bode and Huber, 
1992) As cathepsin L2 was not inhibited by hirudin, this result shows that 
the 3-dimensional structure of the active site of cathepsin L2 is different to the 
structure of the active site of thrombin
The cathepsin B and L specific peptide inhibitor Z-phe-ala-CHN2 was 
included in the fluorogemc assay to determine whether it interfered with the
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cleavage of Tos-gly-pro-arg-NHMec by cathepsin L2 and thrombin (Shaw 
and Dean, 1980) Z-phe-ala-CH2 completely inhibits cathepsin L2 This 
result shows that the P-) alanine and the P2 phenylalanine group of Z-phe- 
ala-CHN2 binds to the S i and S2 subsites in cathepsin L2 respectively, and 
the CHN2 group of this molecule binds covalently to the active site cysteine 
residue However, Z-phe-ala-CHN2 does not inhibit thrombin indicating that 
phenylalanine and alanine do not bind to the S2 and S-) binding sites of this 
enzyme Therefore the studies using Z-phe-ala-CHN2 show that thrombin 
and cathepsin L2 differ in the structures of their active sites
Further evidence to show that cathepsin L2 and thrombin differ in the 
structures of their active sites comes from studies using fibrin-anti- 
polymerants (Laudano and Doolittle, 1980) The two fibrinopeptides, H-gly- 
pro-arg-pro-OH and H-gly-pro-arg-OH decreased the activity of cathepsin L2 
on Tos-gly-pro-arg-NHMec by 60% Under the same conditions thrombin 
activity was inhibited by only 20% These results show that H-gly-pro-arg- 
OH and H-gly-pro-arg-pro-OH are competitive inhibitors of cathepsin L2 but 
not of thrombin
In order to visualise the clotting of fibrinogen in vitro , a fibrinogen 
plate assay was developed In this assay fibrinogen was incorporated into 
agar and poured onto glass slides Wells for were cut into the solidified agar 
and sample was subsequently applied to each well The slides were left to 
incubate overnight in a moist chamber to prevent drying and following 
incubation clotting was observed as opaque zones of precipated fibrin 
against a clear background of soluble fibrinogen When thrombin was added 
to the plate assays an opaque zone due to clotted fibrin was visible 
Likewise when cathepsin L2 was added to the plate assays an opaque zone
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of clotted fibrin was visible In appearance the two types of fibnn zones are 
different as the ring produced by thrombin is more opaque and appears as a 
circle while the zone produced by cathepsin L2 is “ring-like” i e the centre is 
clear while the outside is opaque This observation is consistent with a 
difference in the clotting mechanism of the two enzymes
Fibrin plate assays were performed with the inhibitors hirudin and Z- 
phe-ala-CHN2 The results of the fibrin plate assays with inhibitors were 
similar to those obtained for the fluorogemc substrate inhibition assays i e 
hirudin inhibited thrombin but not cathepsin L2 whilst Z-phe-ala-CHN2 
inhibits cathepsin L2 but not thrombin (see above)
The differences in the clotting mechanisms of cathepsin L2 and 
thrombin was further assessed by tube clotting assays The ability of an 
enzyme to form an insoluble fibrin clot in a test tube is measured by the time 
taken to achieve a solid fibrin clot (Hougie, 1977) The clotting assay was 
used to compare the times of clot formation and hence relative clotting ability 
by cathepsin L2 and thrombin The inhibitors hirudin and Z-phe-ala-CHN2 
were added to clotting time assays to assess the mechanism of action of both 
cathepsin L2 and thrombin The inclusion of hirudin and Z-phe-ala-CHN2 
inhibited the activities of thrombin and cathepsin L2 respectively as 
demonstrated by the increase in clotting times obtained This result confirms 
the results of the peptide substrate assays and the results of the fibrinogen 
plate assays
The clots formed in in vitro clotting assays were analysed using 
reducing SDS-PAGE gels The clots were centrifuged, the supernatant 
removed and the pellets were washed a number of times with PBS 
Reducing sample buffer was added and the clots were denatured by boiling
104
SDS PAGE analysis of solubilised thrombin and cathepsin L2 clots indicated 
that their subunit structures differed In the thrombin produced clots the a, p 
and y subunits of fibrin are still visible The a  and P subunits migrate at
slightly lower molecular weights due to the loss of the A and B 
fibrinopeptides SDS PAGE analysis of the cathepsin L2 produced clots 
revealed that the a and p subunits disappear but the y subunit remains intact 
However, proteins of 100,125 and 25 kDa are visible
When solubilised cathepsin L2 and thrombin clots were transferred to 
nitrocellulose strips and probed with specific anti-fibrinogen antibodies, the 
100,125 and 25 kDa bands were visualised Taken together, these data 
demonstrate that cathepsin L2 cleaves fibrinogen in a different manner to 
thrombin and produces a novel type of fibnn clot The cathepsin L2 clot is 
composed of fibrin subunits which have different molecular weights to the 
fibrin monomers produced by thrombin cleavage The 100 and 125 kDa
molecules may be produced by the polymerisation of the a and p
polypeptides and/or fragments of these This polymerisation reaction is 
covalent because it is not destabilised by reduction with mercaptoethanol 
and denaturation by boiling in the presence of SDS
Clotting time assays were performed with the fibrin anti-poly me rants 
H-gly-pro-arg-pro-OH, H-gly-pro-arg-OH and H-gly-his-arg-pro-OH (Laudano 
and Doolittle, 1980) The fibrin anti-polymerants H-gly-pro-arg-pro-OH and
H-gly-pro-arg-OH correspond to the N-terminal end of the a  subunit of fibrin 
that is exposed following the removal of the A fibrinopeptide by thrombin 
(Iwanga e ta l., 1967, Cottrell and Doolittle, 1976)
H-gly-pro-arg-pro-OH is a more effective anti-polymerant of thrombin
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than H-gly-pro-arg-OH These fibrin anti-polymerants block polymerisation 
by binding to sites where the fibrin monomers normally assemble (Laudano 
and Doolittle, 1980) In mammals the removal of the A fibrinopeptides are 
more important for clot assembly than the removal of the B fibrinopeptides 
(Laudano and Doolittle, 1980)
The anti-polymerant H-gly-his-arg-pro-OH mimics the N-termmal end 
of the (3 subunit exposed after cleavage of the B fibrinopeptide (Iwanga e t  
a l , 1967, Cottrell and Doolittle, 1976) The [3 chain specific fibrin anti- 
polymerants do not prevent fibrin polymerisation of mammalian fibrinogen 
(Laudano and Doolittle, 1980) Only in the more primitive lamprey fibrinogen
does the (3 chain specific synthetic fibrin anti-polymerant inhibit clotting,
which is consistent with the observation that clotting can occur in this animal 
upon the removal of the B fibrinopeptides alone (Laudano and Doolittle, 
1980)
The anti-polymerant H-gly-pro-arg-pro-OH increased the clotting time 
of thrombin The other anti-polymerants H-gly-pro-arg-OH and H-gly-his- 
arg-pro-OH did not increase clotting times In contrast, none of the fibrin anti- 
polymerants adversely affected the clotting ability of cathepsin L2 to any 
significant degree. These results suggest that the cleavage of fibrinogen by 
cathepsin L2 and thrombin must be at different sites in the molecule
The cathepsin L2 cleavage site of fibrinogen was examined using 
clotting time assays Fibrinogen was first pre-incubated with various amounts 
of the fibrin anti-polymerant H-gly-pro-arg-pro-OH Thrombin was then 
added to allow the removal of the fibrinopeptides A and B Therefore fibrin 
was formed by the removal of the fibrinopeptides from fibrinogen but, due to
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the presence of the fibrin anti-polymerant, no clots were formed Thrombin or 
cathepsin L2 were then added to the tubes Thrombin caused clotting only in 
those tubes with a low concentration of anti-polymerant (200 |iM) When 
cathepsin L2 was added, complete clot formation was seen in tubes 
containing 200, 250 and 300 |iM but not 350 and 400 jiM of fibrin anti- 
polymerant The absence of clot formation in the tubes with 350 and 400 mM 
H-gly-pro-arg-pro-OH was not due to its anti-polymerant activity but to its 
competitive inhibition of enzyme activity (see above) Assembly of fibrin 
monomers generated by cathepsin L2 is unaffected by prior cleavage of 
fibrinogen by thrombin indicating that cathepsin L2 cleaves fibrinogen 
towards the C-terminal end of fibnnogen than thrombin
SDS-PAGE analysis of cathepsin L2 clots formed following pre- 
incubation of fibrinogen with thrombin resulted in the same molecular 
structures as incubation of fibrinogen with cathepsin L2 alone Cathepsin L2 
cleaves fibrinogen to produce an identical type of clot irrespective of the 
presence of the A and B fibrinopeptides in the fibrinogen molecule The 
results of SDS-PAGE analysis therefore, confirm that the location of the 
cathepsin L2 fibrinogen cleavage site is further to the b-terminal than the 
thrombin cleavage site
Thrombin and the snake venom proteinases, and now F  hepatica  
cathepsin L2, are the only enzymes described to date which cleave 
fibrinogen to form a fibrin clot (Shieh e t a l , 1985, Pirkle e t a l , 1986, Farid et  
a l , 1989, Dyr et  a l , 1989, Nishida e t  a l , 1994) The snake venom enzymes 
share more similarities to thrombin than they do to cathepsin L2 Firstly, they 
belong to the same proteinase class (senne) as thrombin and share N-
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terminal amino acid sequence similarities (Pirkle e t a l ,  1986, Nishida e t a l ,  
1994, Farid e t a l , 1989) Secondly, the snake venom enzymes cleave 
fibrinogen at the same site as thrombin releasing both fibrinopeptides A and 
B (Pirkle e ta l., 1986, Dyr e t a l , 1989) Some snake venom enzymes differ to 
thrombin in that they release only a single fibrinopeptide (e g bothrombin 
and the Tnm eresurus flavoviridis coagulant enzyme (Nishida e t a l , 1994, 
Shieh e t a l , 1985)) As cathepsin L2 cleaves fibrinogen further to the C- 
terminal of the thrombin cleavage site, it must also cleave fibrinogen at a 
different site to the snake venom protemases Finally, the SDS-PAGE profiles 
of the clots produced by the snake venom enzymes differ to the profiles of the 
clots produced by cathepsin L2 (Farid e t a l , 1989, Pirkle e t a l , 1986) The 
cleavage of fibrinogen by the snake venom protemases do not produce the 
higher molecular weight (100 and 125 kDa) or lower molecular weight (25 
kDa) fibrin polypeptides characteristic of fibrinogen cleavage by cathepsin 
L2 In conclusion, F  hepatica  cathepsin L2 cleaves fibrinogen to form a 
fibrin clot in a novel manner
F  hepatica  is a blood feeder throughout the part of the life cycle that 
exists in the mammalian host Whilst in the bile ducts the parasite gains 
access to the blood primarily by puncturing the bile duct wall It is possible 
that cathepsin L2 plays some role in this feeding habit Possibly, after 
gaining access to the blood, the parasite plugs the wound to prevent 
excessive bleeding The parasite could then repeatedly feed at this access 
point Cathepsin L2 may also be used by the parasite to plug blood vessels 
which it severs while migrating through the gut wall and liver tissue, again 
the purpose being to prevent excessive blood loss from the host tissues
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CONCLUSIONS
A cysteine proteinase was isolated to homogeneity from medium in 
which adult F hepatica  were incubated using gel filtration and amon- 
exchange chromatography
The cysteine proteinase was characterised, by N-terminal amino acid 
sequencing and enzyme kinetic studies with fluorogemc substrates, as a 
cathepsin L
This cysteine proteinase is the second cathepsin L enzyme isolated 
from F hepatica  culture medium and is termed cathepsin L2 Cathepsin L2 
and the previously isolated F hepatica  cysteine proteinase (cathepsin L1, 
Smith e t a l  1994) were differentiated on the basis of substrate specificities
and chemical modification studies with the nitrating reagent TNM
»
Cathepsin L2 (29 5 kDa) is a larger molecule than cathepsin L1 (27 
kDa) and was shown by immunoblotting studies to be a distinct enzyme and 
not the pro-form of cathepsin L1
Cathepsin L2 causes fibrinogen to clot in vitro This clotting activity is 
the first described for a cysteine proteinase, and is shared only with the 
serine proteinase thrombin and snake venom thrombin-like enzymes 
Characterisation of the fibrin clot formed by the cathepsin L2 by 
reducing SDS-PAGE showed that the molecular interactions between the 
fibrin subunits is different to those within a thrombin produced clot 
Cathepsin L2 cleaves fibnnogen further to the C-termmal than the thrombin 
cleavage site and the polypeptides formed by cathepsin L2 cleavage of 
fibrinogen may be cross-linked by covalent interactions
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ABSTRACT The zoonotic hookworm, Ancylostom a canm um , probably induces 
human eosinopholic ententis by inducing allergic responses to its secretions This 
species is already known to secrete metalloproteinases, but in other parasites 
cysteine proteinases are involved in pathogenesis We studied somatic extracts of 
A. canm um  adults and infective larvae and adult excretory/secretory (ES) antigens 
for cysteine proteinase activity using fluorogenic peptide substrates and by gelatin 
and fluorogenic substrate polyacrylamide gel electrophoresis Proteolytic activity 
was observed against the cathepsins L and B-specific substrate Z-phe-arg-AMC, 
against the plasmin substrate Boc-val-leu-lys-AMC, and against gelatin The Z- 
phe-arg-AMC-hydrolyzing activity in ES and in adult extracts was enhanced up to 
15-fold by the reducing agent dithiothreitol (DTT) but was totally blocked by specific 
inhibitors of cysteine proteinases including the peptidyl diazomethyl ketone Z-phe- 
ala-CHN2, E-64, leupeptin and N-ethylmaleimide In like fashion, gelatinolytic 
activity in ES detected using substrate gels was enhanced by the addition of 
reducing agents and inhibited by Z-phe-ala-CHN2 and E-64 The DTT-enhanced, 
Z-phe-arg-AMC hydrolyzing activity in ES was active over a wide pH range from pH 
5 through pH 9 Similar cysteine proteinase activity to that detected in ES was 
present in extracts of adult and infective larvae of A canm um  Because the 
substrate Z-phe-arg-AMC was specifically hydrolyzed, and because this hydrolysis 
was totally blocked by cysteine proteinase-specific inhibitors, ES and tissue extracts 
of A canm um  clearly possess cysteine proteinase activity. Furthermore, since the 
specific activity of Z-phe-arg-AMC-cleaving enzyme was up to five-fold higher in ES 
than in soluble extracts of parasites, the cysteine proteinase is actively secreted by 
adult hookworms This is the first demonstration of cysteine proteinases from
2
hookworms and enlarges the range of potential allergens which may induce human 
eosinophilic ententis
INTRODUCTION
It is now established beyond doubt that the canine hookworm A ncylostom a  
caninum  can develop in the human gut, and in some cases cause eosinophilic 
ententis (EE), a segmental inflammatory lesion of the gastrointestinal trac t1-3 Sera 
from many Australian patients with EE contain high titres of specific IgG and IgE 
antibodies to excretory/secretory (ES) antigens of adult hookworms3 Given that 
protemases released by infectious organisms, including parasitic nematodes have 
been implicated in pathogenic immune reactions,4,5 and that allergic mechanisms 
are involved in EE,6 it is reasonable to assume that protemases released by the 
dog hookworm may invoke hypersensitivity reactions underlying this disease in 
some cases
Hotez and Cerami described the presence of two proteinase activities in 
extracts of adult A. caninum  and recorded that one of these (36 kDa) but not the 
other (40 kDa) was present in the excretory/secretory (ES) products released in 
vitro by these worms7 Charactenzation of the 36 kDa enzyme revealed it to be a 
metallo-proteinase that had elastinolytic activity, and inhibited fibrin clot formation7 
They postulated that it was involved in histolysis and prevented the coagulation of 
blood during feeding 7,8 Subsequent studies demonstrated the presence of the 
metallo-proteinase in A  caninum  larvae9 Preliminary findings indicated several 
bands of proteolytic activity other than those investigated by Hotez e t  at. 7-9 and 
Loukas and coworkers3 In the present study, ES and soluble adult and larval 
extracts of A  caninum  were analyzed for endoproteinase activities distinct from 
these metallo-enzymes We employed a panel of fluorogemc peptide and gelatin 
substrates, in test-tube and polyacrylamide gel electrophoretic assays, and class-
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specific proteinase enhancers and inhibitors We now report that adult and larval 
A canm um  possess cysteine proteinase activity, which is distinct from that 
descnbed by Hotez and colleagues, and which is preferentially secreted by adult 
parasites
MATERIALS AND METHODS 
Parasites, preparation of antigen
Adult A. canm um  hookworms were obtained at autopsy from the small 
intestine of naturally infected dogs, as previously described 10 ES was prepared by 
cultunng adult hookworms in phosphate buffered saline, pH 7 3 (PBS) containing 1 
mM disodium-ethylenediamine-tetraacetic acid (EDTA), 100 U ml*1 penicillin, 100 ng 
streptomycin sulfate and 25 |ig ml'1 amphotencin (CSL, Parkville, Australia). EDTA 
was included in the culture medium in order to inactivate metallo-proteinase activity 
secreted by the parasites3,8 The supernatant was filter-sterilized and concentrated 
as previously described3
Tissue extracts were prepared from approximately 50 adult hookworms (of 
mixed sex), suspended in 500 |il PBS, by two freeze-thaw cycles (-70°C/ 4°C) 
followed by somcation (12 x 10 s bursts at duty cycle 10%, output 5, Branson 
Somfier 250) (Branson Ultrasonics, Danbury, CT), after which the lysate was 
centnfuged at 14,000 x g  for 30 min Infective A. canm um  larvae were recovered 
by an inverted gauze pad method from fecal/charcoal cultures of feces from 
naturally infected dogs Approximately 2 x 106 larvae were washed thoroughly in 
tap water and resuspended in 500 |il PBS. Soluble tissue extracts of larvae were
5
prepared by three freeze-thaw cycles, followed by somcation (5 x 5 s bursts at 
constant duty cycle, output 5, Branson Somfier) and centnfugation as above The 
supernatants were retained as adult (L5) and larval (L3) tissue extracts, 
respectively Protein concentrations of ES and extracts were measured using a 
modified Lowry method (DC Protein Assay, Bio-Rad, Richmond, CA)
Enzyme assays
Proteinase activity was measured using the fluorogemc peptides, 
benzyloxycarbonyl-L-phenylalanyl-L-arginine-7-amido-4-methyl-coumann (Z-phe- 
arg-AMC), benzyloxycarbonyl-L-arginyl-L-argimne-7-amido-4-methylcoumann (Z- 
arg-arg-AMC), benzoyl-L-arginine-7-amido-4-methylcoumarin (Bz-arg-AMC), tosyl-L- 
glycyl-L-prolyl-L-lysine-7-amido-4-methylcoumarin (Tos-gly-pro-lys-AMC), tosyl-L- 
glycyl-L-prolyl-L-arginine-7-amido-4-methylcoumarin (Tos-gly-pro-arg-AMC) and t- 
butyloxycarbonyl-L-valyl-L-leucyl-lysine-7-amido-4-methylcoumann (Boc-val-leu-lys- 
AMC) (Bachem, Bubendorf, Switzerland), as substrates. Peptide substrates were 
prepared as 10 mg ml'1 stock solutions in dimethylformanrnde ES and tissue 
extracts (0 3 |xg -18  6 |ig) were incubated in PBS containing 10 |xM fluorogemc 
substrate at 37°C for 30 minutes, after which the reaction was stopped by the 
addition of glacial acetic acid to 300 mM The reducing agent dithiothreitol (DTT) 
(Boehnnger Mannheim, Castle Hill, Australia) was included in some fluonmetnc 
assays at a concentration of 500 jiM 11 The release of the fluorescent group 7- 
amino-4-methylcoumann (AMC) was measured using a fluorimeter (Kontron, model 
SFM 25, Milan, Italy) with excitation at 370 nm and emission at 440 nm The 
amount of enzymatically-generated AMC was calculated from the standard
6
fluorescence intensity of authentic AMC (Sigma Chemical Co , St Louis, MO)
One unit (U) of enzyme activity was defined as that amount which catalyzed the 
release of one nmol AMC min'1 mg protein'1 at 37°C.
Buffers for measuring pH/activity profile
The pH/activity profile of the Z-phe-arg-AMC-cleaving activity in ES (0 3 jig) 
was examined with the following buffers Fifty mM glycine was adjusted to pH 2 8 - 
3 6 with 200 mM HCI Acetate buffer for measuring activity in the pH range 3 6 - 
5.6 was adjusted by mixing 100 mM acetic acid and 100mM sodium acetate. 
Phosphate buffer for measunng activity in the pH range 5 9 - 7 3  was adjusted by 
mixing 100 mM monobasic sodium phosphate and 100 mM dibasic sodium 
phosphate Fifty mM Tris for measunng activity in the pH range 7 6 - 8.8 was 
adjusted with 200 mM HCI Fifty mM glycine was adjusted to pH 9.2 -10.6  with 
200 mM NaOH The final salt concentration of each buffer was adjusted to 100 
mM using 500 mM NaCI calculated using the Henderson-Hasselbach equation 12 
Each buffer was supplemented with 500 nM DTT
Fluorogenic- and gelatin-substrate polyacrylamide gels
Adult ES (1 25 (xg -12.5 (xg) was separated by non-denaturing, non-SDS, 
polyacrylamide gel electrophoresis using gels co-polymerized with the proteinase 
substrate gelatin at 0 1% (GS-PAGE).13 (GS-PAGE was employed without SDS or 
reducing agents in the sample or electrophoresis buffers because they may inhibit 
the hydrolysis of synthetic peptidyl AMC substrates [Dowd, unpublished, see also 
ref. 14]) Following electrophoresis, gels were washed for 1 h in PBS, pH 7 3
(three changes) For fluorogemc substrate analysis, GS-PAGE gels were 
immersed in 10 |j.M fluorgemc substrate in PBS supplemented with the reducing 
agent cysteine at 10 mM for 30 min at 37°C. AMC-hydrolyzing activity was 
visualized by transilluminating the gels at 302 nm after which they were 
photographed using Polaroid 667 film After fluorimetric analysis, gels were 
incubated in 10 mM cysteine in PBS at 37°C overnight, and stained subsequently 
with Coomassie Brilliant Blue R250 in order to detect gelatinolytic activity13 In 
addition, some samples were analyzed solely for gelatinolyic activity by GS-PAGE
Inhibition analysis
Proteinase inhibitors were obtained from Sigma, L-irans-epoxysuccinyl-l- 
leucylamido-(4-guamdino)-butane (E-64), N-ethylmaleimide (NEM), soybean trypsin 
inhibitor (SBTI), EDTA, phenylmethylsulfonyl fluonde (PMSF), leupeptin, and 
pepstatin A; or from Bachem, benzyloxycarbonyl-L-phenylalanyl-L-alanme- 
diazomethylketone (Z-phe-ala-CHN2) Adult ES (0 3 jig) was mixed with inhibitors 
at appropriate concentrations (Z-phe-ala-CHN2, 500 nM, E-64, 14 nM, NEM, 5 mM, 
leupeptin, 6 |iM; PMSF, 1 mM, SBTI, 5 |iM, EDTA, 10 mM, and pepstatin A, 70 
j iM ) after which proteolytic activities were analyzed by test-tube fluorometnc 
analysis, as above In addition, ES samples (1 25 |ig) separated by GS-PAGE 
were incubated overnight in 28 (xM E-64 or 1 |xM Z-phe-ala-CHN2 in PBS 
supplemented with 10 mM cysteine
9RESULTS 
Proteinase activity in Ancylostoma caninum adults and larvae
Extracts of A. caninum  larvae and adults, and adult ES were assayed for 
cysteine proteinase activity using the fluorogemc peptide substrate Z-phe-arg-AMC 
Proteinase activity capable of cleaving this substrate was detected in ES, and from 
extracts of larvae and adults. The proteinase activity in extracts of adult worms 
and ES was enhanced 9- to 15-fold in the presence of the reducing reagent DTT, 
and up to two-fold in larval extracts By contrast, the Z-phe-arg-AMC hydrolysis 
detected in the presence of DTT was totally or substantially inhibited in all parasite 
fractions by the addition of 500 ^M Z-phe-ala-CHN2, a specific inhibitor of 
cathepsin-like cysteine proteinases (Table 1)
Cysteine proteinase responsible for cleavage of Z-phe-arg-AMC
The proteinase activity responsible for the cleavage of Z-phe-arg-AMC was 
enhanced by the addition of the reducing agent DTT and blocked by the addition of 
Z-phe-ala-CHN2 (see above) In order to determine the class(es) of endopeptidase 
responsible for the protease activity in ES, ES (0 3 |xg) was incubated with the 
fluorogemc substrate Z-phe-arg-AMC in the presence of class-specific proteinase 
inhibitors, and hydrolysis of AMC from the substrate measured by fluorescence 
spectrometry Incubation of ES and Z-phe-arg-AMC with each of four specific 
inhibitors of cysteine proteinases (Z-phe-ala-CHN2, E-64, NEM, and leupeptin) 
reduced enzyme activity by 94-100% In contrast, inhibitors of aspartic (pepstatin 
A), senne (soybean trypsin inhibitor, and PMSF), and metallo-proteinases (EDTA)
had little or no inhibitory effect on the hydrolysis of Z-phe-arg-AMC (not shown)
pH/activity profile
The pH dependence of the A caninum  cysteine proteinase activity against 
the substrate Z-phe-arg-AMC was determined in vanous buffers in which the salt 
concentration of each buffer was adjusted to 100 mM to minimize salt 
concentration effects on proteinase activity. Potent Z-phe-arg-AMC hydrolyzing 
activity was observed from pH 5 through 9 In contrast, the activity fell rapidly at 
pHs below 5 and above 9 (Figure 1)
GS-PAGE analysis of A. caninum ES
A. caninum  ES was analyzed under non-reducing conditions by GS-PAGE, 
conditions expected to separate proteins on the basis of molecular size and electnc 
charge15 A single band of gelatinolytic activity was detected and this activity was 
substantially enhanced in the presence of cysteine In contrast, the activity was 
blocked by the specific cysteine proteinase inhibitors, E-64 (28 |iM) and Z-phe-ala- 
CHN2 (1 jiM) (Figure 2)
Substrate specificity of A. caninum ES cysteine proteinase
Having detected, measured, and inhibited the A. caninum  proteinase activity 
in test-tube and gel assays, we attempted to visualize the fluorogemc activity in 
gels and to characterize its peptidyl substrate specificity ES was subjected to GS- 
PAGE, after which replicate gel lanes were incubated in 10 ^iM fluorogenic 
substrate in PBS supplemented with 10 mM cysteine. Vigorous AMC-hydrolyzing
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activity co-migrating with the gelatmolytic activity was observed with the substrate 
Z-phe-arg-AMC, activity was also observed with Boc-val-leu-lys-AMC, whereas little 
or no activity was observed in these gels after incubation in the substrates Bz-arg- 
AMC (Figure 3), Tos-gly-pro-arg-AMC, and Tos gly-pro-lys-AMC, and Z-arg-arg- 
AMC (not shown).
In addition, ES was incubated in the presence of DTT with a panel of 
flourogemc peptide substrates in tube assays to further characterize the substrate 
specificity of the cysteine proteinase The substrate Z-phe-arg-AMC was 
preferentially cleaved by the endopeptidase activity in ES Boc-val-leu-lys-AMC 
was also cleaved, although to a lesser degree than Z-phe-arg-AMC. In contrast, 
little or no hydrolysis of Tos-gly-pro-arg-AMC, Tos-gly-pro-lys-AMC, and Z-arg-arg- 
AMC was detected (Table 2)
Preferential secretion of cysteine proteinase by adult hookworms
In order to determine whether the cysteine proteinase was preferentially 
secreted by adult hookworms, the specific activity of the cysteine proteinase in ES 
was compared with that from adult tissue extracts The activity in ES was 
approximately five-fold higher than the proteinase activity in homogenates, 
indicating that the cysteine proteinase was preferentially secreted in ES by the 
adult hookworms (Table 1)
DISCUSSION
Proteinases are employed by parasitic worms in various pathologic 
processes including degradation of the extracellular dermal matnx dunng skin
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penetration, hydrolysis of hemoglobin, inhibition of host protective immune 
responses including cleavage of immunoglobulin and complement components and, 
in addition, are known to invoke hypersensitivity reactions16,17 We have begun to 
investigate protemases released by hookworms in order to determine their role in 
parasitism, and in particular to examine whether hookworm protemases are 
associated with the allergic responses in humans manifested as eosinophilic 
ententis This study demonstrates for the first time that the zoonotic hookworm A  
canm um  synthesizes and secretes a cysteine (i e thiol dependent) proteinase 
activity capable of hydrolyzing gelatin and the synthetic peptide substrates Z-phe- 
arg-AMC and Boc-val-leu-lys-AMC.
The hydrolysis of Z-phe-arg-AMC was thiol-dependent because the activity 
was enhanced up to 15-fold by the addition of the thiol-containing reagents DTT 
and cysteine Since Z-phe-arg-AMC, a substrate normally used to assay the 
cysteine protemases cathepsins B and L, was cleaved by the hookworm enzyme, 
whereas the cathepsin B-specific substrate Z-arg-arg-AMC and the cathepsin H 
substrate Bz-arg-AMC were not readily cleaved, the activity is cathepsin L-like 18 
The Z-phe-arg-AMC hydrolysis was blocked by the cysteine proteinase-specific 
inhibitors E-64 and Z-phe-ala-CHN2, venfying that a cysteine proteinase in ES and 
tissue extracts was responsible for the Z-phe-arg-AMC hydrolysis19,20 Cysteine 
protemases contain a thiol group which is essential for proteolytic activity and 
require reducing reagents in vitro to stabilize and/or enhance activity This 
essential thiol group is often found to be blocked under both natural and 
expenmental conditions, but can be unblocked by reducing agents11 NEM, an 
agent which alkylates thiol groups, inhibited the thiol-dependent hookworm
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activity21 Leupeptin, a peptide aldehyde and a reversible inhibitor of cysteine 
proteinases, also inhibited the thiol-dependent proteolytic activity18 By contrast, 
specific inhibitors of senne, metallo-, and aspartic proteinases had no significant 
inhibitory effect on the Z-phe-arg-AMC cleaving activity in ES The cysteine 
proteinase appears to be actively secreted by adult A. canm um  because the 
specific activity against the fluorogemc substrate Z-phe-arg-AMC was 5-fold higher 
in ES than in adult worm extracts
Using casein-agar gels, Hotez and Cerami7 detected metallo-proteinase 
activities in extracts of adult Ancylostom a canm um  and observed that one (36 kDa) 
but not the other (40 kDa) was present in the ES released m  vitro by hookworms. 
We strategically included the metal chelator, EDTA, in the hookworm culture media 
to inactivate these metallo-proteinases so that other activities masked or degraded 
by metallo-proteinases might be detected The thiol-dependent activity reported 
here appears to be distinct from the metallo-proteinase characterized by Hotez and 
co-workers4,7-9 In particular, the metallo-proteinase is inhibited by EDTA and 1,10 
phenanthroline whereas cysteine proteinase inhibitors exert little or no inhibition8 
By contrast, the Z-phe-arg-AMC hydrolyzing activity was not inhibited by EDTA 
Furthermore, the metallo-proteinase has a pH optimum of 10 and is inactive at 
neutral pH,8 that pH dependence is patently different to that of the cathepsin L-like 
activity reported here, since this activity was shown to be active over a broad pH 
range (pH 5-9) It is of interest to note that cysteine proteinases released by 
several other parasites are active at neutral and alkaline pH,22,23 although 
proteolytic activity at acid pH is usual for cathepsins B and L 18
Proteinase activity in the hookworm ES and extracts was also shown to
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cleave Boc-val-leu-lys-AMC, a substrate cleaved by plasmin in vitro This suggests 
that the proteolytic activity may have anti-coagulant functions24 The thrombin-like 
fluorogemc substrates Tos-gly-pro-lys-AMC and Tos-gly-pro-arg-AMC24 were not 
readily hydrolyzed by the proteinase
While a protein of apparent molecular weight 68 kDa appears to be the 
most specific diagnostic antigen for human infection with A. canm um  on Western 
blots, the identity of the putative allergen(s) is not known3 Since the cysteine 
proteinase activity descnbed here is apparently secreted by adult A. canm um , and 
since proteinases released by other parasitic helminths provoke IgE antibody 
responses and elicit immediate type hypersensitivity responses in infected humans 
and mice,17,25,26 the cathepsin L-like proteinase and the previously reported metallo- 
proteinases may play a role in the pathology of eosinophilic enteritis.
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Table 1 Enhancement and inhibition of cysteine proteinase activity of
A nyclostom a canm um  fractions The activity of each fraction was 
measured against the fluorogemc substrate Z-phe-arg-AMC.
Fraction -DTT +DTT Enhancement +DTT
+Z-phe-ala-CHN2
Inhibition
U* U* -fold U* %
L3 extract 0 5 08 1 6 0 2 75
L5** extract 7.7 66 4 9 7.4 89
L5 ES 21 3 330 5 15 0 100
Enzyme activity units (U) are defined as nmoles AMC released min'1 mg worm 
protein'1 The cysteine proteinase-specific enhancer dithiothreitol (DTT) was 
used at a concentration of 500 |iM and the cathepsin-specific inhibitor Z-phe-ala- 
CHN2 at 500 nM
"  before in vitro culture
Table 2 Specific activities of proteinase from A ncylostom a canm um  ES 
measured against fluorogemc peptide substrates
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Substrate Activity (U)*
Z-phe-arg-AMC 330 5
Z-arg-arg-AMC 1.1
Tos-gly-pro-arg-AMC 13 1
Tos-gly-pro-lys-AMC 6 3
Boc-val-leu-lys-AMC 48 5
Units (U) of enzyme activity are defined as nmoles AMC released min'1 mg worm 
protein1
FIGURE LEGENDS
Figure 1. pH dependence of Ancylostoma caninum thiol-dependent cysteine 
proteinase activity. Adult A. caninum ES (0.3 |ig) was incubated in 50 mM glycine- 
HCI pH 2.8 - 3.6, 100 mM acetate pH 3.6 - 5.6, 100 mM sodium phosphate pH 5.9 
- 7.3, 50 mM Tris-HCI pH 7.6 - 8.8 and 50 mM glycine-NaOH pH 9.2 - 10.6. 
Cysteine proteinase activity was measured against the cathepsins B- or L-like 
substrate Z-phe-arg-AMC in the presence of the reducing agent dithiothrietol (DTT).
Figure 2. Demonstration of proteinase activity in excretory/secretory products (ES) 
from adult Ancylostoma caninum. ES (1.25 |xg) was separated by electrophoresis 
through non-denaturing, non-SDS gels containing co-polymerized gelatin. After 
electrophoresis, gel strips were incubated in the absence (lane 1) or presence (lane 
2) of cysteine and the cysteine proteinase inhibitors E-64 (lane 3) and Z-phe-ala- 
CHN2 (lane 4). The results demonstrate that ES contains only one major 
proteinase activity capable of hydrolysis of the gelatin substrate, and that this 
activity is ascribable to a cysteine proteinase.
Figure 3. Substrate specificity of Ancylostoma caninum thiol-dependent, cysteine 
proteinase activity. Adult A. caninum ES (12.5 |ig) was separated by 
electrophoresis through non-denaturing, non-SDS gels containing co-polymerized 
gelatin. Panel A, cleavage of gelatin; panel B, cleavage of peptide fluorogenic 
substrates, Z-phe-arg-AMC (FR, lane 1), Boc-val-leu-lys-AMC (VLK, lane 2), and 
Bz-arg-AMC (R, lane 3). Together, the results show that the proteinase activity 
capable of cleaving the general purpose substrate gelatin also preferentially
cleaves the specific, cathepsin B- or L-like substrate Z-phe-arg-AMC
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